US20040058408A1 - Microfabricated apparatus for cell based assays - Google Patents

Microfabricated apparatus for cell based assays Download PDF

Info

Publication number
US20040058408A1
US20040058408A1 US10/650,412 US65041203A US2004058408A1 US 20040058408 A1 US20040058408 A1 US 20040058408A1 US 65041203 A US65041203 A US 65041203A US 2004058408 A1 US2004058408 A1 US 2004058408A1
Authority
US
United States
Prior art keywords
cells
cell growth
channel
cell
chambers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/650,412
Inventor
Nicholas Thomas
Per Andersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyros Patent AB
Original Assignee
Gyros AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyros AB filed Critical Gyros AB
Priority to US10/650,412 priority Critical patent/US20040058408A1/en
Assigned to GYROS AB reassignment GYROS AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ANDERSSON, PER
Publication of US20040058408A1 publication Critical patent/US20040058408A1/en
Assigned to GYROS PATENT AB reassignment GYROS PATENT AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NORADA HOLDING AB
Assigned to NORADA HOLDING AB reassignment NORADA HOLDING AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GYROS AB
Priority to US11/397,401 priority patent/US7935522B2/en
Priority to US12/236,120 priority patent/US8030062B2/en
Assigned to AMERSHAM PHARMACIA BIOTECH UK LTD. reassignment AMERSHAM PHARMACIA BIOTECH UK LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THOMAS, NICHOLAS
Assigned to GYROS AB reassignment GYROS AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERSHAM PHARMACIA BIOTECH AB
Priority to US13/231,430 priority patent/US20120003682A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/16Microfluidic devices; Capillary tubes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/38Caps; Covers; Plugs; Pouring means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/16Particles; Beads; Granular material; Encapsulation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0803Disc shape
    • B01L2300/0806Standardised forms, e.g. compact disc [CD] format
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/087Multiple sequential chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0877Flow chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/10Means to control humidity and/or other gases
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0409Moving fluids with specific forces or mechanical means specific forces centrifugal forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0688Valves, specific forms thereof surface tension valves, capillary stop, capillary break

Definitions

  • the present invention relates to cell based assays.
  • the invention relates to a microfabricated apparatus for performing cell growth and cell based assays and to methods for performing such assays.
  • Such assays include bioavailability, metabolism and toxicology, and they are carried out predominantly using cultured cell lines.
  • secondary. screening assays have a much higher level of complexity and more stringent requirements, both in the mechanics of the assay and in the information generated.
  • secondary screening assay methodologies which are capable of handling both the increasing rate of putative drug lead generation and the generation of biological data concerning the drug candidate.
  • development of assays yielding higher information content have the potential to increase the level of characterisation of a lead drug during the screening phase of drug development.
  • WO 96/15450 discloses a device which comprises an etched glass structure with a collection of chambers connected by a micro-channel and enclosed by a glass cover plate.
  • Devices have been described by Wilding et al., for example in WO 93/22058, which discloses a mesoscale device for amplifying DNA by PCR, the device consisting of a number of chambers connected by a channel.
  • WO 93/22055 and WO 93/22053 relate to devices for analysing a fluid cell-containing sample comprising a mesoscale flow system with entry port for capture and/or lysis of cells in biological fluids, or containing a binding moiety for specifically binding an analyte, where the analyte may be an intracellular component in a cell in a sample, or a cell population in a sample.
  • the above devices are concerned with the measurement or detection of cells or cellular analytes in cells introduced into the device immediately prior to analysis. They are not described for use in cell culture or growth, nor for use in the study of cellular responses to agents under test. Moreover, they do not describe or permit the use of adherent cultured cells.
  • the present invention provides apparatus microfabricated for performing cell growth and cell based assays in a liquid medium, said apparatus comprising:
  • the method for studying the effect of a test substance includes the step of culturing cells adhering to a surface within the apparatus prior to the introduction of the test substances.
  • FIG. 1 a is a diagrammatic representation in plan of an individual micro-channel element of the microfabricated apparatus for performing cell growth and cell based assays;
  • FIG. 1 b is a sectional view of a microfabricated disc including a plurality of assay elements for performing cell growth and cell based assays according to the present invention
  • FIG. 2 represents an alternative configuration of an individual assay element of the microfabricated apparatus for use with cells growing on the surface of microcarrier beads;
  • FIG. 3 represents a further configuration of an individual assay element of the microfabricated apparatus in which means are provided for preventing or impeding the passage of cells in the cell growth chamber.
  • the apparatus of the present invention comprises a rotatable disc ( 18 ) microfabricated to provide a sample introduction port (not shown) located towards the centre of the disc and connected to an annular sample reservoir ( 9 ) which in turn is connected to a plurality of radially dispersed micro-channel assay elements ( 6 ) each of said micro-channel elements comprising a cell growth chamber, a sample inlet channel and an outlet channel for removal of liquid therefrom and a cover plate positioned onto said disc so as to define closed chambers and connecting channels.
  • Each micro-channel element is connected at one end to the central sample reservoir ( 9 ) and at the opposing end to a common waste channel ( 10 ).
  • Each of the radially-dispersed micro-channel elements ( 6 ) of the microfabricated apparatus comprises a sample inlet channel ( 1 ) connected at its left hand-end end to the reservoir ( 9 ), a cell growth chamber ( 2 ) for performing cell growth and connected through a channel ( 4 ) to an assay chamber ( 3 ) and an outlet channel ( 5 ) connected at its right-hand end to the waste channel ( 10 ).
  • each micro-channel element ( 6 ) is modified to permit the use of the apparatus with cells growing on the surface of microcarrier beads ( 17 ).
  • each micro-channel element ( 6 ) comprises a sample inlet channel ( 8 ) connected at its left-hand end to the sample reservoir ( 9 ), a cell growth chamber ( 7 ) connecting through a channel ( 16 ) to an assay chamber ( 11 ), and an outlet channel ( 12 ) leading to the common waste channel ( 10 ).
  • the cell growth chamber ( 2 ) may be provided with raised moulded structures disposed on the base portion of the cell growth chamber to form pillars ( 15 ), such that they form a barrier to the flow or passage of cells arriving in the cell growth chamber ( 2 ) through the inlet channel ( 1 ), while allowing the passage of liquid.
  • These structures are of dimensions chosen to provide gaps between the structures which are too narrow to allow passage of cells carried as a suspension in liquid moving in the device, but which are sufficiently large to allow cells growing on the surface of the cell growth chamber ( 14 ) to migrate through the barrier by extension of cell processes between the barrier and subsequent cytokinesis. Suitable dimensions for the gaps between the raised pillars ( 15 ) formed in the cell. growth chambers are between 5 and 50 ⁇ m, depending upon the cell type and cell size selected for capture.
  • each micro-channel element ( 6 ) shown in FIG. 3 additionally includes one or more assay chambers for performing assays involving cellular constituents and being connected in line between said cell growth chamber ( 2 ) and said outlet channel ( 5 ).
  • the disc ( 18 ) is of a one- or two-piece moulded construction and is formed of an optionally transparent plastic or polymeric material by means of separate mouldings which are assembled together to provid a closed structure with openings at defined positions to allow loading of the device with liquids and removal of waste liquids.
  • the device is produced as two complementary parts, one or each carrying moulded structures which, when affixed together, form a series of interconnected micro-channel elements within the body of a solid disc.
  • the micro-channel elements may be formed by micro-machining methods in which the micro-channels and chambers forming the micro-channel elements are micro-machined into the surface of a disc, and a cover plate, for example a plastic film, is adhered to the surface so as to enclose the channels and chambers.
  • one or more components of the device may be constructed from a gas permeable plastic, film, polymer, or membrane.
  • the gas permeable plastic, film, polymer, or membrane is formed from silicone polymers, such as polydimethylsiloxane, or from polyurethane, polytetrafluoroethylene or other gas permeable plastic materials.
  • means are preferably provided for sealing the openings in the closed structure to prevent evaporation of liquid during use, whereby such means seal the openings without interfering with gas exchange to the cell growth medium. Sealing can be accomplished by use of a further layer of gas permeable material across the whole device, or by use of a non-permeable material applied locally to the openings only, leaving the remainder of the gas permeable material exposed to the local atmosphere.
  • Suitable plastic or polymeric materials for forming the cell growth chamber and micro-channels are preferably selected to have hydrophobic properties, where the surface of the plastic or polymer can be additionally selectively modified by chemical or physical means to alter the surface properties to confer a desired property, for example, compatibility with cell growth, cell attachment and the attachment of biomolecules by covalent or non-covalent means.
  • Preferred plastics are selected from polystyrene and polycarbonate.
  • the cell growth chamber and micro-channels may be constructed from plastic or polymeric materials which are selected to have hydrophilic properties.
  • the surface of the plastic or polymer can be additionally selectively modified by chemical or physical means to alter the surface properties so as to produce localised regions of hydrophobicity within the chambers and/or microchannels to confer a desired property.
  • hydrophobic barriers or valves may be provided to control liquid flow within the apparatus.
  • Preferred plastics are selected from polymers with a charged surface, suitably chemically or ion-plasma treated polystyrene, polycarbonate or other rigid transparent polymers.
  • the micro-channel elements ( 6 ) are dispersed radially around the disc ( 18 ) and connected to a common centre port.
  • the channels 1 , 4 , 5 , 8 , 12 , and 16 are of a dimension compatible with movement of cells along the channels.
  • the channels and chambers may be of any cross-sectional shape, such as square, rectangular, circular, trapezoid and triangular.
  • the cell growth chamber ( 2 ) is sized to give a floor area between 100 ⁇ m 2 and 1,000,000 ⁇ m 2 , preferably between 1000 ⁇ m 2 and 1,000,000 ⁇ m 2 and most preferably between 10,000 ⁇ m 2 and 1,000,000 ⁇ m 2 .
  • the plastic or polymer surface of the cell growth chamber may be selectively treated or modified to permit cell attachment and/or growth. Treatment preferably involves exposure to intense UV light to modify the polymer surface or alternatively the use of high voltage plasma discharge using known techniques (see Amstein, C. F. and Hartmann, P. A., J.Clin.Microbiol., 2,1, 46-54 (1975)) to create a negatively charged surface suitable for cell growth and attachment and (if required) for assay purposes. Cell attachment may be further improved by the application of additional coatings to the surface of the cell growth chamber, eg. polylysine, collagen, fibronectin.
  • additional coatings eg. polylysine, collagen, fibronectin.
  • each of the micro-channel elements ( 6 ) is further provided with an assay chamber ( 3 ) which is located in line between the cell growth chamber ( 2 ) and the outlet channel ( 5 ), for performing assays involving cellular constituents.
  • the assay chamber is sized proportionally to the volume of the cell growth chamber ( 2 ) to allow collection and/or capture of soluble analytes which may be derived from the cultured cells under study.
  • the volume of the assay chamber ( 3 ) is between twice and one tenth of the volume of the cell growth chamber ( 2 ).
  • the channel ( 4 ) which connects the cell growth chamber and the assay chamber is characterised by having hydrophobic walls and a cross-sectional area which is smaller than the channel ( 1 ) upstream of the cell growth chamber.
  • channel ( 4 ) has a cross-sectional area of between 0.99 and 0.01 times that of the inlet channel ( 1 ).
  • the outlet channel ( 5 ) is characterised by having hydrophobic walls and a cross-sectional area of between 0.99 and 0.01 times that of channel ( 4 ).
  • liquid flow in the micro-channel elements can be controlled by application of a defined centrifugal force to cause the liquid to flow in a channel of a defined cross-sectional area, wherein the same force is insufficient to cause the liquid to flow in further linked channels of lesser cross-sectional area, this having the effect of stopping the liquid flow at a desired position in the micro-channel element.
  • channel ( 1 ) and channel ( 4 ) are constructed with the same cross-sectional area, but the surface of each of the channels may be selectively modified by chemical or physical means to confer a different degree of hydrophobicity on that channel.
  • channel ( 4 ) downstream of the cell growth chamber ( 2 ) may be treated to have a higher hydrophobicity than the channel ( 1 ) upstream of the cell growth chamber.
  • Suitable means for selectively modifying the hydrophobicity of the surface of the channels include exposure of defined areas to ionizing or electromagnetic radiation or ion plasma through a mask, or by application of a hydrophobic material or ink by screen printing or other means of localized application.
  • the means of controlling liquid flow within the apparatus as described above may be used alone or in combination as required, in order to confer the desired control of liquid flow in connected chambers and channels within the micro-channel element.
  • the methods may be used sequentially, for example where a change in cross-sectional area is followed by a change in hydrophobicity, forming two sequential points of liquid flow control.
  • the methods may be used coincidentally, in which a change in cross-sectional area of a channel is accompanied by a change in hydrophobicity of that channel, the combination being used to confer a degree of control over liquid flow not attainable using a single means.
  • the inner surface of the assay chamber may be coated with one or more ligands capable of specifically binding an analyte of interest by covalently or non-covalently linking the ligand to the surface.
  • ligands suitable for the purpose include: biotin, streptavidin, protein A, antibodies, lectins, hormone receptors, nucleic acid probes, DNA binding proteins and the like.
  • the apparatus and method can be used for the growth of cells and the detection and measurement of cellular activity, cellular parameters and biochemical processes, for example cellular metabolism, cell viability, reporter gene expression, using non-invasive techniques, that is techniques which do not compromise the integrity or viability of cells.
  • the apparatus may be used in the detection and measurement of cell-derived products, which have been released or otherwise excreted from cells, such as peptide hormones, second messengers, etc.
  • the apparatus permits studies of cell migration in response to chemical or physical stimuli, for example chemotaxis, wherein a chemoattractant substance is placed on one side of a barrier and cells placed on the opposite side of the barrier are observed to penetrate the barrier in moving toward the chemoattractant.
  • chemical or physical stimuli for example chemotaxis
  • the invention may be used with any cell type that can be cultured on standard tissue culture plastic-ware.
  • Such cell types include all normal and transformed cells derived from any recognised source with respect to species (eg. human, rodent, simian), tissue source (eg. brain, liver, lung, heart, kidney skin, muscle) and cell type leg. epithelial, endothelial).
  • tissue source eg. brain, liver, lung, heart, kidney skin, muscle
  • cell type leg. epithelial, endothelial e. epithelial, endothelial
  • cells which have been transfected with recombinant genes may also be cultured using the invention.
  • There are established protocols available for the culture of diverse cell types See for example, Freshney, R. I., Culture of Animal Cells: A Manual of Basic Technique, 2 nd Edition, Alan R. Liss inc. 1987).
  • Such protocols may require the use of specialised coatings and selective media to enable cell growth and the expression of specialist cellular functions. None of such protocols is
  • the scale of the device will to a certain extent be dictated by its use, that is the device will be of a size which is compatible with use with eukaryotic cells. This will impose a lower limit on any channel designed to allow movement of cells and will determine the size of cell containment or growth areas according to the number of cells present in each assay.
  • An average mammalian cell growing as an adherent culture has an area of ⁇ 300 ⁇ m 2 ; non-adherent cells and non-attached adherent cells have a spherical diameter of ⁇ 10 ⁇ m. Consequently channels for movement of cells within the device are likely to have dimensions of the order of 20-30 ⁇ m or greater.
  • Sizes of cell holding areas will depend on the number of cells required to carry out an assay (the number being determined both by sensitivity and statistical requirements). It is envisaged that a typical assay would require a minimum of 500-1000 cells which for adherent cells would require structures of 150,000-300,000 ⁇ m 2 , i.e. circular ‘wells’ of ⁇ 400-600 ⁇ m diameter.
  • the configuration of the micro-channels in the present invention is preferably chosen to allow simultaneous seeding of the cell growth chamber by application of a suspension of cells in a fluid medium to the sample reservoir by means of the sample inlet port, followed by rotation of the disc ( 18 ) by suitable means at a speed sufficient to cause movement of the cell suspension outward towards the periphery of the disc by centrifugal force.
  • the movement of liquid distributes the cell suspension along each of the inlet micro-channels ( 1 , 8 ) towards the cell growth chambers ( 2 , 7 ).
  • the rotation speed of the disc is chosen provide sufficient centrifugal force to allow liquid to flow to fill the cell growth chamber ( 2 , 7 ), but with insufficient force for liquid to enter the restricted channel ( 4 , 16 ) of smaller diameter on the opposing side of the cell growth chamber.
  • the device may be rotated at a higher speed than previously, such that all liquid and unattached cells is caused to move towards the periphery of the disc into the waste channel ( 10 ) disposed around the edge of disc. Following clearance of channels of unattached cells, rotation is slowed to the same speed initially used to fill the micro-channel elements and fresh cell culture media is applied to the sample reservoir.
  • the cell culture media flows under centrifugal force to fill the micro-channels and the cell growth chambers as previously described. This action leaves the attached cells seeded on the surface of the cell growth chambers covered in fresh culture media suitable for cell growth and for cell based assays.
  • the beads ( 17 ) provide a large surface area for cell attachment and growth in a relatively small volume of liquid.
  • the beads ( 17 ) perform two functions; firstly they provide a surface for the attachment and growth of cells, so removing the need to provide a cell-growth compatible surface within the disc allowing a wider range of materials to be used for construction, and secondly they provide a larger physical carrier for cells which allows channels within the device to be easily designed to prevent access of cells.
  • each element comprises a cell growth chamber ( 2 , 7 ), an analysis chamber ( 3 , 11 ), and a waste chamber ( 10 ) which are arranged radially about the centre of the disc and connected to a common port in the centre of the disc.
  • reagents and samples for assay may be introduced into the sample reservoir ( 9 ) through the sample inlet port.
  • Reagents to be supplied to all micro-channel elements may be introduced as described hereinbefore for seeding with cells, that is by applying a solution containing reagents to the central port and rotating the disc so as to cause distribution of the reagent to all micro-channels, cell growth chambers and assay chambers.
  • the application of specific samples to specific wells may be achieved by pipetting small volumes of liquid as discrete drops into the central well directly adjacent to the opening of the inlet channel leading to the cell growth chamber which is to receive the sample.
  • liquids may be pipetted as discrete drops onto the hydrophobic surface of a stationary disc ( 18 ), rotation of the disc being used to move these drops of liquid into the appropriate inlet channel and so to the cell growth chamber.
  • a stationary disc 18
  • all reagents and samples may be provided to the cell chamber in the desired order and proportions to perform the assay.
  • the liquid manipulations of the assay have been performed it is necessary to perform a detection procedure to measure the result of the assay, typically by measuring the signal emitted by a fluorescent, chemiluminescent or other labelling moiety.
  • the device as shown in FIG. 1 b is configured to allow two means of detection of the assay signal. Firstly, the assay signal may be measured in-situ in the cell growth chamber. Such a signal would be typified by the measurement of the product of a reporter gene within the cells, e.g. fluorescence from GFP.
  • the apparatus is provided with a second chamber, ie. the assay chamber ( 3 , 11 ) disposed closer to the periphery of the disc and connected to the cell growth chamber ( 2 , 7 ).
  • the assay chamber is connected to the peripheral waste channel ( 10 ) by a narrow channel ( 5 , 12 ), this channel having a smaller diameter than that ( 4 , 16 ) connecting the assay chamber to the cell growth chamber.
  • the differential in diameters between chambers allows, under controlled conditions of rotation and centrifugal force, as discussed above, liquid to be moved from the cell growth chamber to the assay chamber.
  • an analyte is moved from the cell growth chamber into the assay chamber where the analyte is subject to affinity capture by a ligand attached to the wall of the assay chamber.
  • This process therefore provides a means of moving a cell-derived analyte, which has been released or otherwise excreted from cells, away from the cellular environment, immobilising the analyte within the assay chamber by means of a specific binding partner for binding to the analyte, and allowing subsequent additions of reagents and processing to permit the detection of the analyte.
  • Suitable detectable labels may be selected from fluorescent labels, chemi-luminescent labels, bio-luminescent labels, enzyme labels and radioactive labels.
  • Suitable fluorescent labels for tagging reagents according to the method of the invention may be selected from the general categories of fluorescent dyes, including, but not limited to, fluoresceins, rhodamines, cyanine dyes, coumarins, and the BODIPY groups of fluorescent dyes. Examples of bioluminescent detectable labels are to be found in the fluorescent reporter proteins, such a Green Fluorescent Protein (GFP) and aequorin.
  • Alternative labels for providing a detectable signal can be fluorescence energy transfer labels.
  • measurement of the signal may be achieved by means appropriate to the labelling molecule or moiety used in the assay and is typically by optical means.
  • luminescence emitted from cells or from a fluorescent labelled assay reagent may be detected in the microfabricated apparatus by the use of imaging apparatus incorporating a CCD camera, or by the use of a fluorimeter. Detection of emitted fluorescence may be achieved through the body of the disc ( 18 ) where the disc is wholly constructed of a transparent material or alternatively through windows of transparent material which have been fabricated into the body of the disc.
  • the apparatus of the present invention may be used in conjunction with radioactive detection utilising the scintillation proximity technique.
  • scintillant-containing beads may be introduced into the apparatus.
  • the microfabricated apparatus of the invention may have incorporated a scintillant containing layer into or onto an interior surface of the cell growth chamber ( 2 , 7 ) and/or the assay chamber ( 3 , 11 ).
  • the region of the apparatus containing the scintillant beads or scintillant surface is preferably optically transparent so as to enable the material to transmit light at a given wavelength with optimum efficiency.
  • the scintillant-containing region can be composed of any transparent material containing scintillant, eg. a scintillant glass based on lanthanide metal-containing compounds, or a plastic material such as polystyrene or polyvinyltoluene, into which is incorporated the scintillant substance.
  • Suitable scintillant substances can include aromatic hydrocarbons such as p-terphenyl, p-quaterphenyl and their derivatives, and derivatives of oxazoles and 1,3,4-oxadiazoles, for example, 2-(4-t-butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole and 2,5-diphenyloxazole.
  • a wavelength shifter such as 1,4-bis(5-phenyl-2-oxazolyl)benzene, or 9,10-diphenylanthracene, may also be included.
  • a binding moiety such as one member of a specific binding pair may be immobilised onto the surface of the bead or scintillant layer so as to specifically bind with an analyte which may be derived from cells used in the assay process.
  • Suitable specific binding pair members with which the invention is useful include biotin, streptavidin, protein A, antibodies, lectins, hormone receptors, nucleic acid probes, DNA binding proteins and the like. It is to be understood that either member of the specific binding pair may be attached and immobilised for binding to a complementary member of the specific binding pair.
  • Typical radioistopes that may be used to label the assay reagent include those commonly used in biochemistry such as [ 3 H], [ 125 I], [ 35 S] and [ 33 P] but does not preclude the use of other isotopes.
  • Detection methodologies based on scintillation proximity are well known (see for example U.S. Pat. No. 4,568,649, Bertoglio-Matte,J.). Detection may utilise a number of modalities to be combined to allow all assays to be measured simultaneously or in rapid succession.
  • an appropriate imaging format may provide suitable detection means for both radioactive and non-radioactive assays utilising the apparatus.
  • some assay areas will be redundant; that is, not all elements of the apparatus will be used every time. It is envisaged that the user will decide what type of assays it is required to perform and then select appropriate control means for directing liquid flow within the apparatus. Consequently, such structures will be compatible with a range of assay procedures and protocols which require different complexities of fluid movement. For example, detection of a GFP linked reporter gene will require a simple well structure to allow measurement of fluorescence.
  • analyte secreted from cells for example the measurement of a cytokine by immunoassay, or measurement of cellular mRNA following lysis, will require a more complicated structure to separate the cells from the secreted analyte prior to the analysis of that analyte
  • a stock culture of HeLa cells was grown in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% calf serum and L-glutamine in a plastic flask using standard tissue culture conditions. Cells were harvested by trypsinisation and the resulting suspension concentrated by centrifugation to give a cell concentration of 10 7 cells/ml. Aliquots of the cell suspension (1 ⁇ l) were applied to openings in the surface of a microfabricated structure of the type shown in FIG. 1, produced by injection moulding, with internal channels of depth 50 ⁇ m and width 100 ⁇ m.
  • DMEM Dulbecco's Modified Eagles Medium
  • the cells suspension was moved along the inlet channels within the disc to circular cell growth chambers of depth 50 ⁇ m and diameter 500 ⁇ m and the cells allowed to attach and grow. Following incubation for 48 hours in a tissue culture incubator (37° C./95% RH) the cells were examined for cell density, morphology and viability. Visible examinations by phase contrast microscopy showed cell populations growing in microstructures to have the same density and morphology as control cultures grown from the same parent stock and maintained in standard tissue culture plasticware.
  • Cells were subsequently tested for viability using a commercial test kit (LIVE/DEAD Viability Kit, Molecular Probes, Oregon, L-3224) by flushing growth medium from the cells within the device, washing the cells with a phosphate buffered saline solution (PBS) and introducing a solution of the fluorescent assay reagents into the cell growth chambers. Subsequent examination by fluorescent microscopy showed that cells growing in microstructures had maintained a cell viability of >95%, comparable with control cells grown under standard tissue culture conditions.
  • PBS phosphate buffered saline solution
  • a stock culture of HeLa cells was grown in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% calf serum and L-glutamine in a plastic flask using standard tissue culture conditions. Cells were harvested by trypsinisation and the resulting suspension concentrated by centrifugation to give a cell concentration of 10 7 cells/ml. Aliquots of the cell suspension (1 ⁇ l) were applied to openings in the surface of the device and cells moved along the channels by rotation about the disc axis (1000 rpm for 30 seconds). Following incubation for 18 hours in a tissue culture incubator (37° C./95% RH) cells were examined by phase contrast microscopy.
  • DMEM Dulbecco's Modified Eagles Medium
  • HeLa cells grown and harvested as described above were introduced into the device of Example 2 into micro channels which contained moulded pillars of various dimensions dispersed in the channels so as to act as barriers to cell movement in the channels.
  • a suspension of cell was introduced into the channels and the structure incubated for 18 hours to allow the cells to settle and grow.
  • Subsequent examination revealed that in channels where the gaps between pillars were 10 ⁇ 60 ⁇ m or greater cells were observed to have moved freely past the barriers.
  • gaps between pillars were 10 ⁇ 20 ⁇ m or less
  • cells were prevented from passing the barrier when transported by liquid flow in suspension.
  • Such barrier structures may prove useful for study of cell movement or migration in response to chemical or physical stimuli.
  • HeLa cells transfected to yield stable expression of a Calreticulin-GFP fusion protein were introduced into a moulded apparatus of the type shown in FIG. 1, supporting channels of 100 ⁇ m width and 100 ⁇ m depth connected to circular chambers of 600 ⁇ m and 1000 ⁇ m diameter and 100 ⁇ m depth. Cells were incubated for 18 hours in a tissue culture incubator and examined by confocal fluorescence microscopy. Cells grown in microfabricated structures showed the same level of GFP expression as control cells grown under conventional tissue culture conditions.
  • HeLa cells were grown and introduced into a microfabricated disc as described in Example 1. Following incubation for 18 hours growth medium was removed from cells and replaced with media containing different concentrations of the membrane permeabilising agent digitonin in the range 0-0.2 mg/ml (w/v) and cells incubated in the presence of digitonin for 10 minutes. Thereafter the viability of the cells was measured as described in Example 1. Results were found to be equivalent to cells exposed to the same dose range of digitonin in a microtitre plate based assay.

Abstract

Apparatus and methods are provided for performing cell growth and cell based assays in a liquid medium. The apparatus comprises a base plate supporting a plurality of micro-channel elements, each micro-channel element comprising a cell growth chamber, an inlet channel and an outlet channel, a cover plate positioned over the base plate to define the chambers and connecting channels. Means are incorporated in the cell growth chambers, for cell attachment and cell growth. In particular, the invention provides a rotatable disc microfabricated for performing cell growth and cell based assays. The apparatus and method can be used for the growth of cells and the detection and measurement of a variety of biochemical processes and products using non-invasive techniques, that is techniques which do not compromise the integrity or viability of cells.

Description

  • The present invention relates to cell based assays. In particular the invention relates to a microfabricated apparatus for performing cell growth and cell based assays and to methods for performing such assays. [0001]
  • The current focus in high throughput screening applications towards the screening of increasing numbers of compounds is being driven by the twin technologies of combinatorial chemistry and genomics, in order to produce new potential drug targets and novel candidate drugs as potential therapeutic compounds. The primary screening process has been addressed by the development of high throughput screening assay processes and assay miniaturisation utilising the microtitre well plate format with 384, 864, 1536 or greater miniaturised wells. Miniaturised assays are capable of allowing throughput levels of over 100,000 tests/day in primary screening. At this level of throughput, a primary screen might be expected to yield 100-1000 ‘hits’ per day. Each of these putative drugs is required to undergo further refined screening and testing in a variety of assays in order to investigate the biological compatibility of the compound. Such assays include bioavailability, metabolism and toxicology, and they are carried out predominantly using cultured cell lines. In comparison with assays used in the primary screening process, secondary. screening assays have a much higher level of complexity and more stringent requirements, both in the mechanics of the assay and in the information generated. There is a requirement in the art for secondary screening assay methodologies which are capable of handling both the increasing rate of putative drug lead generation and the generation of biological data concerning the drug candidate. In addition, development of assays yielding higher information content have the potential to increase the level of characterisation of a lead drug during the screening phase of drug development. [0002]
  • Microfabricated devices have been described previously which are suitable for use in miniaturized biological analyses. For example, WO 96/15450 discloses a device which comprises an etched glass structure with a collection of chambers connected by a micro-channel and enclosed by a glass cover plate. Devices have been described by Wilding et al., for example in WO 93/22058, which discloses a mesoscale device for amplifying DNA by PCR, the device consisting of a number of chambers connected by a channel. WO 93/22055 and WO 93/22053 relate to devices for analysing a fluid cell-containing sample comprising a mesoscale flow system with entry port for capture and/or lysis of cells in biological fluids, or containing a binding moiety for specifically binding an analyte, where the analyte may be an intracellular component in a cell in a sample, or a cell population in a sample. The above devices are concerned with the measurement or detection of cells or cellular analytes in cells introduced into the device immediately prior to analysis. They are not described for use in cell culture or growth, nor for use in the study of cellular responses to agents under test. Moreover, they do not describe or permit the use of adherent cultured cells. [0003]
  • There is a requirement for a device capable of providing an environment which supports the long term survival of cultured cells, coupled with means to utilise cells cultured within the device for secondary drug screening or other studies. [0004]
  • In one aspect, the present invention provides apparatus microfabricated for performing cell growth and cell based assays in a liquid medium, said apparatus comprising: [0005]
  • a) a base plate supporting a plurality of micro-channel elements, each comprising a cell growth chamber, an inlet channel for supplying liquid sample thereto and an outlet channel for removal of liquid sample therefrom; [0006]
  • b) a cover plate positioned over said base plate said cover plate extending over said elements so as to define said chambers and connecting channels; said cover plate being supplied with holes to provide access to said channels; and [0007]
  • c) means, incorporated in said cell growth chambers, for cell attachment and cell growth. [0008]
  • In a second aspect of the invention there is provided a method for studying the effect of a test substance on a cellular activity or physical parameter by the use of the apparatus as defined, which method comprises: [0009]
  • a) providing a suspension of cells in a fluid medium; [0010]
  • b) introducing said cells into said apparatus and causing said cells to be transported to one or more cell growth chambers in said apparatus; [0011]
  • c) providing one or more samples of test substances whose effect upon the cells is to be measured under conditions so as to cause said cells to be exposed to said substances; [0012]
  • d) determining the effect of the test substances on said cells by means of optical detection. [0013]
  • Preferably the method for studying the effect of a test substance includes the step of culturing cells adhering to a surface within the apparatus prior to the introduction of the test substances. Preferably there are provided following step c) one or more assay reagents and dispersing the reagents to one or more reaction chambers in the apparatus. [0014]
  • In a further aspect of the present invention there is provided a method for measuring a cellular analyte by the use of the apparatus as defined, which method comprises: [0015]
  • a) providing a suspension of cells containing an analyte to be measured in a fluid medium; [0016]
  • b) introducing cells into the apparatus and causing the cells to be transported to one or more cell growth chambers in the apparatus; [0017]
  • c) allowing cells to grow; [0018]
  • d) providing one or more assay reagents and dispersing the reagents to one or more chambers in the apparatus; [0019]
  • e) measuring the cellular analyte by optical means.[0020]
  • In order that the invention may be better understood, several embodiments will now be described by way of example only and with reference to the accompanying drawings in which: [0021]
  • FIG. 1[0022] a is a diagrammatic representation in plan of an individual micro-channel element of the microfabricated apparatus for performing cell growth and cell based assays;
  • FIG. 1[0023] b is a sectional view of a microfabricated disc including a plurality of assay elements for performing cell growth and cell based assays according to the present invention;
  • FIG. 2 represents an alternative configuration of an individual assay element of the microfabricated apparatus for use with cells growing on the surface of microcarrier beads; and [0024]
  • FIG. 3 represents a further configuration of an individual assay element of the microfabricated apparatus in which means are provided for preventing or impeding the passage of cells in the cell growth chamber.[0025]
  • Referring to FIG. 1[0026] b, the apparatus of the present invention comprises a rotatable disc (18) microfabricated to provide a sample introduction port (not shown) located towards the centre of the disc and connected to an annular sample reservoir (9) which in turn is connected to a plurality of radially dispersed micro-channel assay elements (6) each of said micro-channel elements comprising a cell growth chamber, a sample inlet channel and an outlet channel for removal of liquid therefrom and a cover plate positioned onto said disc so as to define closed chambers and connecting channels. Each micro-channel element is connected at one end to the central sample reservoir (9) and at the opposing end to a common waste channel (10).
  • Each of the radially-dispersed micro-channel elements ([0027] 6) of the microfabricated apparatus (shown in FIG. 1a) comprises a sample inlet channel (1) connected at its left hand-end end to the reservoir (9), a cell growth chamber (2) for performing cell growth and connected through a channel (4) to an assay chamber (3) and an outlet channel (5) connected at its right-hand end to the waste channel (10).
  • In an alternative format of the present invention as shown in FIG. 2, the micro-channel elements ([0028] 6) are modified to permit the use of the apparatus with cells growing on the surface of microcarrier beads (17). Thus, each micro-channel element (6) comprises a sample inlet channel (8) connected at its left-hand end to the sample reservoir (9), a cell growth chamber (7) connecting through a channel (16) to an assay chamber (11), and an outlet channel (12) leading to the common waste channel (10).
  • With reference to FIG. 3, in a further embodiment of the apparatus, the cell growth chamber ([0029] 2) may be provided with raised moulded structures disposed on the base portion of the cell growth chamber to form pillars (15), such that they form a barrier to the flow or passage of cells arriving in the cell growth chamber (2) through the inlet channel (1), while allowing the passage of liquid. These structures are of dimensions chosen to provide gaps between the structures which are too narrow to allow passage of cells carried as a suspension in liquid moving in the device, but which are sufficiently large to allow cells growing on the surface of the cell growth chamber (14) to migrate through the barrier by extension of cell processes between the barrier and subsequent cytokinesis. Suitable dimensions for the gaps between the raised pillars (15) formed in the cell. growth chambers are between 5 and 50 μm, depending upon the cell type and cell size selected for capture.
  • Preferably, each micro-channel element ([0030] 6) shown in FIG. 3 additionally includes one or more assay chambers for performing assays involving cellular constituents and being connected in line between said cell growth chamber (2) and said outlet channel (5).
  • Suitably the disc ([0031] 18) is of a one- or two-piece moulded construction and is formed of an optionally transparent plastic or polymeric material by means of separate mouldings which are assembled together to provid a closed structure with openings at defined positions to allow loading of the device with liquids and removal of waste liquids. In the simplest form, the device is produced as two complementary parts, one or each carrying moulded structures which, when affixed together, form a series of interconnected micro-channel elements within the body of a solid disc. Alternatively the micro-channel elements may be formed by micro-machining methods in which the micro-channels and chambers forming the micro-channel elements are micro-machined into the surface of a disc, and a cover plate, for example a plastic film, is adhered to the surface so as to enclose the channels and chambers.
  • To provide cultured cells with means for obtaining oxygen for metabolism and to permit use of CO[0032] 2-buffered media, one or more components of the device may be constructed from a gas permeable plastic, film, polymer, or membrane. Suitably, the gas permeable plastic, film, polymer, or membrane is formed from silicone polymers, such as polydimethylsiloxane, or from polyurethane, polytetrafluoroethylene or other gas permeable plastic materials. In addition, means (not shown) are preferably provided for sealing the openings in the closed structure to prevent evaporation of liquid during use, whereby such means seal the openings without interfering with gas exchange to the cell growth medium. Sealing can be accomplished by use of a further layer of gas permeable material across the whole device, or by use of a non-permeable material applied locally to the openings only, leaving the remainder of the gas permeable material exposed to the local atmosphere.
  • Suitable plastic or polymeric materials for forming the cell growth chamber and micro-channels are preferably selected to have hydrophobic properties, where the surface of the plastic or polymer can be additionally selectively modified by chemical or physical means to alter the surface properties to confer a desired property, for example, compatibility with cell growth, cell attachment and the attachment of biomolecules by covalent or non-covalent means. Preferred plastics are selected from polystyrene and polycarbonate. [0033]
  • Alternatively, the cell growth chamber and micro-channels may be constructed from plastic or polymeric materials which are selected to have hydrophilic properties. The surface of the plastic or polymer can be additionally selectively modified by chemical or physical means to alter the surface properties so as to produce localised regions of hydrophobicity within the chambers and/or microchannels to confer a desired property. By this means, for example, hydrophobic barriers or valves may be provided to control liquid flow within the apparatus. Preferred plastics are selected from polymers with a charged surface, suitably chemically or ion-plasma treated polystyrene, polycarbonate or other rigid transparent polymers. [0034]
  • The micro-channel elements ([0035] 6) are dispersed radially around the disc (18) and connected to a common centre port. The channels 1, 4, 5, 8, 12, and 16 are of a dimension compatible with movement of cells along the channels. Suitably, the channels and chambers may be of any cross-sectional shape, such as square, rectangular, circular, trapezoid and triangular. Suitably, the cell growth chamber (2) is sized to give a floor area between 100 μm2 and 1,000,000 μm2, preferably between 1000 μm2 and 1,000,000 μm2 and most preferably between 10,000 μm2 and 1,000,000 μm2. The plastic or polymer surface of the cell growth chamber may be selectively treated or modified to permit cell attachment and/or growth. Treatment preferably involves exposure to intense UV light to modify the polymer surface or alternatively the use of high voltage plasma discharge using known techniques (see Amstein, C. F. and Hartmann, P. A., J.Clin.Microbiol., 2,1, 46-54 (1975)) to create a negatively charged surface suitable for cell growth and attachment and (if required) for assay purposes. Cell attachment may be further improved by the application of additional coatings to the surface of the cell growth chamber, eg. polylysine, collagen, fibronectin.
  • As already mentioned, in the preferred aspect of the invention, each of the micro-channel elements ([0036] 6) is further provided with an assay chamber (3) which is located in line between the cell growth chamber (2) and the outlet channel (5), for performing assays involving cellular constituents. The assay chamber is sized proportionally to the volume of the cell growth chamber (2) to allow collection and/or capture of soluble analytes which may be derived from the cultured cells under study. Suitably, the volume of the assay chamber (3) is between twice and one tenth of the volume of the cell growth chamber (2). Advantageously, the channel (4) which connects the cell growth chamber and the assay chamber is characterised by having hydrophobic walls and a cross-sectional area which is smaller than the channel (1) upstream of the cell growth chamber. Suitably, channel (4) has a cross-sectional area of between 0.99 and 0.01 times that of the inlet channel (1). Suitably, the outlet channel (5) is characterised by having hydrophobic walls and a cross-sectional area of between 0.99 and 0.01 times that of channel (4). In this way, liquid flow in the micro-channel elements can be controlled by application of a defined centrifugal force to cause the liquid to flow in a channel of a defined cross-sectional area, wherein the same force is insufficient to cause the liquid to flow in further linked channels of lesser cross-sectional area, this having the effect of stopping the liquid flow at a desired position in the micro-channel element.
  • In an alternative means of controlling liquid flow, channel ([0037] 1) and channel (4) are constructed with the same cross-sectional area, but the surface of each of the channels may be selectively modified by chemical or physical means to confer a different degree of hydrophobicity on that channel. For example, channel (4) downstream of the cell growth chamber (2) may be treated to have a higher hydrophobicity than the channel (1) upstream of the cell growth chamber. By this means, application of a defined force to liquid in channel (1), sufficient to cause liquid to move down this channel will be insufficient to cause that liquid to enter the second channel (4) of higher hydrophobicity, this having the effect of stopping the liquid flow at a desired position in the micro-channel element. Suitable means for selectively modifying the hydrophobicity of the surface of the channels include exposure of defined areas to ionizing or electromagnetic radiation or ion plasma through a mask, or by application of a hydrophobic material or ink by screen printing or other means of localized application.
  • The means of controlling liquid flow within the apparatus as described above may be used alone or in combination as required, in order to confer the desired control of liquid flow in connected chambers and channels within the micro-channel element. If used in combination, the methods may be used sequentially, for example where a change in cross-sectional area is followed by a change in hydrophobicity, forming two sequential points of liquid flow control. Alternatively, the methods may be used coincidentally, in which a change in cross-sectional area of a channel is accompanied by a change in hydrophobicity of that channel, the combination being used to confer a degree of control over liquid flow not attainable using a single means. [0038]
  • The inner surface of the assay chamber may be coated with one or more ligands capable of specifically binding an analyte of interest by covalently or non-covalently linking the ligand to the surface. Examples of ligands suitable for the purpose include: biotin, streptavidin, protein A, antibodies, lectins, hormone receptors, nucleic acid probes, DNA binding proteins and the like. [0039]
  • The apparatus and method can be used for the growth of cells and the detection and measurement of cellular activity, cellular parameters and biochemical processes, for example cellular metabolism, cell viability, reporter gene expression, using non-invasive techniques, that is techniques which do not compromise the integrity or viability of cells. Alternatively, the apparatus may be used in the detection and measurement of cell-derived products, which have been released or otherwise excreted from cells, such as peptide hormones, second messengers, etc. By use of the apparatus shown in FIG. 3, the apparatus permits studies of cell migration in response to chemical or physical stimuli, for example chemotaxis, wherein a chemoattractant substance is placed on one side of a barrier and cells placed on the opposite side of the barrier are observed to penetrate the barrier in moving toward the chemoattractant. [0040]
  • The invention may be used with any cell type that can be cultured on standard tissue culture plastic-ware. Such cell types include all normal and transformed cells derived from any recognised source with respect to species (eg. human, rodent, simian), tissue source (eg. brain, liver, lung, heart, kidney skin, muscle) and cell type leg. epithelial, endothelial). In addition, cells which have been transfected with recombinant genes may also be cultured using the invention. There are established protocols available for the culture of diverse cell types. (See for example, Freshney, R. I., Culture of Animal Cells: A Manual of Basic Technique, 2[0041] nd Edition, Alan R. Liss inc. 1987). Such protocols may require the use of specialised coatings and selective media to enable cell growth and the expression of specialist cellular functions. None of such protocols is precluded from use with the apparatus of this invention.
  • The scale of the device will to a certain extent be dictated by its use, that is the device will be of a size which is compatible with use with eukaryotic cells. This will impose a lower limit on any channel designed to allow movement of cells and will determine the size of cell containment or growth areas according to the number of cells present in each assay. An average mammalian cell growing as an adherent culture has an area of ˜300 μm[0042] 2; non-adherent cells and non-attached adherent cells have a spherical diameter of ˜10 μm. Consequently channels for movement of cells within the device are likely to have dimensions of the order of 20-30 μm or greater. Sizes of cell holding areas will depend on the number of cells required to carry out an assay (the number being determined both by sensitivity and statistical requirements). It is envisaged that a typical assay would require a minimum of 500-1000 cells which for adherent cells would require structures of 150,000-300,000 μm2, i.e. circular ‘wells’ of ˜400-600 μm diameter.
  • The configuration of the micro-channels in the present invention is preferably chosen to allow simultaneous seeding of the cell growth chamber by application of a suspension of cells in a fluid medium to the sample reservoir by means of the sample inlet port, followed by rotation of the disc ([0043] 18) by suitable means at a speed sufficient to cause movement of the cell suspension outward towards the periphery of the disc by centrifugal force. The movement of liquid distributes the cell suspension along each of the inlet micro-channels (1, 8) towards the cell growth chambers (2, 7). The rotation speed of the disc is chosen provide sufficient centrifugal force to allow liquid to flow to fill the cell growth chamber (2, 7), but with insufficient force for liquid to enter the restricted channel (4, 16) of smaller diameter on the opposing side of the cell growth chamber.
  • Once rotation has stopped, cells in the suspension can settle under gravity onto the bottom of the cell growth chamber ([0044] 2, 7) and attach to the treated surface if present. Cells which remain in the channel are unable to attach to the untreated hydrophobic surface and will remain in suspension. Therefore, following an appropriate period of time, chosen to allow cell attachment to take place, the device may be rotated at a higher speed than previously, such that all liquid and unattached cells is caused to move towards the periphery of the disc into the waste channel (10) disposed around the edge of disc. Following clearance of channels of unattached cells, rotation is slowed to the same speed initially used to fill the micro-channel elements and fresh cell culture media is applied to the sample reservoir. By rotation of the disc once more, the cell culture media flows under centrifugal force to fill the micro-channels and the cell growth chambers as previously described. This action leaves the attached cells seeded on the surface of the cell growth chambers covered in fresh culture media suitable for cell growth and for cell based assays.
  • In the apparatus of FIG. 2, the beads ([0045] 17) provide a large surface area for cell attachment and growth in a relatively small volume of liquid. In the device described herein, the beads (17) perform two functions; firstly they provide a surface for the attachment and growth of cells, so removing the need to provide a cell-growth compatible surface within the disc allowing a wider range of materials to be used for construction, and secondly they provide a larger physical carrier for cells which allows channels within the device to be easily designed to prevent access of cells. In the preferred embodiment, each element comprises a cell growth chamber (2, 7), an analysis chamber (3, 11), and a waste chamber (10) which are arranged radially about the centre of the disc and connected to a common port in the centre of the disc.
  • Following the addition of cell samples to the apparatus, their attachment and subsequent cell growth, reagents and samples for assay may be introduced into the sample reservoir ([0046] 9) through the sample inlet port. Reagents to be supplied to all micro-channel elements may be introduced as described hereinbefore for seeding with cells, that is by applying a solution containing reagents to the central port and rotating the disc so as to cause distribution of the reagent to all micro-channels, cell growth chambers and assay chambers. The application of specific samples to specific wells may be achieved by pipetting small volumes of liquid as discrete drops into the central well directly adjacent to the opening of the inlet channel leading to the cell growth chamber which is to receive the sample. This may be achieved, for example, by the use of a piezo-electric dispensing device (not shown), whereby dispensing of droplets of liquid from the device is synchronised with the speed of rotation of the disc (18) such that, at an appropriate combination of dispensing drop frequency and rotation speed of the disc, individual droplets of liquid can be caused to impinge on the surface of the disc and can be caused to be transported by centrifugal force into an adjacent inlet channel (1, 8) and to mix with liquid present in the cell growth chamber (2, 7).
  • Alternatively liquids may be pipetted as discrete drops onto the hydrophobic surface of a stationary disc ([0047] 18), rotation of the disc being used to move these drops of liquid into the appropriate inlet channel and so to the cell growth chamber. By these means, all reagents and samples may be provided to the cell chamber in the desired order and proportions to perform the assay.
  • Once the liquid manipulations of the assay have been performed it is necessary to perform a detection procedure to measure the result of the assay, typically by measuring the signal emitted by a fluorescent, chemiluminescent or other labelling moiety. The device as shown in FIG. 1[0048] b is configured to allow two means of detection of the assay signal. Firstly, the assay signal may be measured in-situ in the cell growth chamber. Such a signal would be typified by the measurement of the product of a reporter gene within the cells, e.g. fluorescence from GFP.
  • Alternatively, it may be desirable to measure cell-derived products or analytes, for example by immunochemical or other specific binding assay methods, in the absence of cells cultured in the apparatus, so as to avoid interference in measurement. In this case, the apparatus is provided with a second chamber, ie. the assay chamber ([0049] 3, 11) disposed closer to the periphery of the disc and connected to the cell growth chamber (2, 7). The assay chamber is connected to the peripheral waste channel (10) by a narrow channel (5, 12), this channel having a smaller diameter than that (4, 16) connecting the assay chamber to the cell growth chamber. The differential in diameters between chambers allows, under controlled conditions of rotation and centrifugal force, as discussed above, liquid to be moved from the cell growth chamber to the assay chamber. For example, by this process, an analyte is moved from the cell growth chamber into the assay chamber where the analyte is subject to affinity capture by a ligand attached to the wall of the assay chamber. This process therefore provides a means of moving a cell-derived analyte, which has been released or otherwise excreted from cells, away from the cellular environment, immobilising the analyte within the assay chamber by means of a specific binding partner for binding to the analyte, and allowing subsequent additions of reagents and processing to permit the detection of the analyte.
  • Optionally, at least one of the reagents for use in an assay method utilising the apparatus may be labelled with a detectable label by covalent or non-covalent attachment. Suitable detectable labels may be selected from fluorescent labels, chemi-luminescent labels, bio-luminescent labels, enzyme labels and radioactive labels. Suitable fluorescent labels for tagging reagents according to the method of the invention may be selected from the general categories of fluorescent dyes, including, but not limited to, fluoresceins, rhodamines, cyanine dyes, coumarins, and the BODIPY groups of fluorescent dyes. Examples of bioluminescent detectable labels are to be found in the fluorescent reporter proteins, such a Green Fluorescent Protein (GFP) and aequorin. Alternative labels for providing a detectable signal can be fluorescence energy transfer labels. [0050]
  • Once the assay has been completed, measurement of the signal may be achieved by means appropriate to the labelling molecule or moiety used in the assay and is typically by optical means. For example, luminescence emitted from cells or from a fluorescent labelled assay reagent may be detected in the microfabricated apparatus by the use of imaging apparatus incorporating a CCD camera, or by the use of a fluorimeter. Detection of emitted fluorescence may be achieved through the body of the disc ([0051] 18) where the disc is wholly constructed of a transparent material or alternatively through windows of transparent material which have been fabricated into the body of the disc.
  • As an alternative to non-radioactive detection, the apparatus of the present invention may be used in conjunction with radioactive detection utilising the scintillation proximity technique. For example, scintillant-containing beads may be introduced into the apparatus. Alternatively the microfabricated apparatus of the invention may have incorporated a scintillant containing layer into or onto an interior surface of the cell growth chamber ([0052] 2, 7) and/or the assay chamber (3, 11). The region of the apparatus containing the scintillant beads or scintillant surface is preferably optically transparent so as to enable the material to transmit light at a given wavelength with optimum efficiency. The scintillant-containing region can be composed of any transparent material containing scintillant, eg. a scintillant glass based on lanthanide metal-containing compounds, or a plastic material such as polystyrene or polyvinyltoluene, into which is incorporated the scintillant substance.
  • Suitable scintillant substances can include aromatic hydrocarbons such as p-terphenyl, p-quaterphenyl and their derivatives, and derivatives of oxazoles and 1,3,4-oxadiazoles, for example, 2-(4-t-butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole and 2,5-diphenyloxazole. A wavelength shifter such as 1,4-bis(5-phenyl-2-oxazolyl)benzene, or 9,10-diphenylanthracene, may also be included. [0053]
  • A binding moiety such as one member of a specific binding pair may be immobilised onto the surface of the bead or scintillant layer so as to specifically bind with an analyte which may be derived from cells used in the assay process. Suitable specific binding pair members with which the invention is useful include biotin, streptavidin, protein A, antibodies, lectins, hormone receptors, nucleic acid probes, DNA binding proteins and the like. It is to be understood that either member of the specific binding pair may be attached and immobilised for binding to a complementary member of the specific binding pair. [0054]
  • Typical radioistopes that may be used to label the assay reagent include those commonly used in biochemistry such as [[0055] 3H], [125I], [35S] and [33P] but does not preclude the use of other isotopes. Detection methodologies based on scintillation proximity are well known (see for example U.S. Pat. No. 4,568,649, Bertoglio-Matte,J.). Detection may utilise a number of modalities to be combined to allow all assays to be measured simultaneously or in rapid succession. Alternatively an appropriate imaging format may provide suitable detection means for both radioactive and non-radioactive assays utilising the apparatus.
  • In some uses, some assay areas will be redundant; that is, not all elements of the apparatus will be used every time. It is envisaged that the user will decide what type of assays it is required to perform and then select appropriate control means for directing liquid flow within the apparatus. Consequently, such structures will be compatible with a range of assay procedures and protocols which require different complexities of fluid movement. For example, detection of a GFP linked reporter gene will require a simple well structure to allow measurement of fluorescence. In contrast, measurement of an analyte secreted from cells, for example the measurement of a cytokine by immunoassay, or measurement of cellular mRNA following lysis, will require a more complicated structure to separate the cells from the secreted analyte prior to the analysis of that analyte [0056]
  • The invention is further illustrated by reference to the following examples. [0057]
  • EXAMPLES 1
  • A stock culture of HeLa cells was grown in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% calf serum and L-glutamine in a plastic flask using standard tissue culture conditions. Cells were harvested by trypsinisation and the resulting suspension concentrated by centrifugation to give a cell concentration of 10[0058] 7 cells/ml. Aliquots of the cell suspension (1 μl) were applied to openings in the surface of a microfabricated structure of the type shown in FIG. 1, produced by injection moulding, with internal channels of depth 50 μm and width 100 μm.
  • The cells suspension was moved along the inlet channels within the disc to circular cell growth chambers of depth 50 μm and diameter 500 μm and the cells allowed to attach and grow. Following incubation for 48 hours in a tissue culture incubator (37° C./95% RH) the cells were examined for cell density, morphology and viability. Visible examinations by phase contrast microscopy showed cell populations growing in microstructures to have the same density and morphology as control cultures grown from the same parent stock and maintained in standard tissue culture plasticware. Cells were subsequently tested for viability using a commercial test kit (LIVE/DEAD Viability Kit, Molecular Probes, Oregon, L-3224) by flushing growth medium from the cells within the device, washing the cells with a phosphate buffered saline solution (PBS) and introducing a solution of the fluorescent assay reagents into the cell growth chambers. Subsequent examination by fluorescent microscopy showed that cells growing in microstructures had maintained a cell viability of >95%, comparable with control cells grown under standard tissue culture conditions. [0059]
  • EXAMPLE 2
  • A microfabricated plastic disc of the type shown in FIG. 1, produced by injection moulding which contained a number of radial internal channels of depth 50 μm and width 100 μm was selectively surface modified by exposure to a 500W UV lamp at a distance of 20 cm for 30 minutes through a metal mask such that UV light impinged on the surface only on regions defined by the mask. [0060]
  • A stock culture of HeLa cells was grown in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% calf serum and L-glutamine in a plastic flask using standard tissue culture conditions. Cells were harvested by trypsinisation and the resulting suspension concentrated by centrifugation to give a cell concentration of 10[0061] 7 cells/ml. Aliquots of the cell suspension (1 μl) were applied to openings in the surface of the device and cells moved along the channels by rotation about the disc axis (1000 rpm for 30 seconds). Following incubation for 18 hours in a tissue culture incubator (37° C./95% RH) cells were examined by phase contrast microscopy. Cells were found to be preferentially growing in regions of the disc previously exposed to UV light, cells in other regions were observed to be sparser and less well attached. The disc was then rotated at 1000 rpm for 30 seconds and cells re-examined. Following spinning cells in UV exposed areas were observed to have remained attached to the plastic surface and remained morphologically identical to control cells; in contrast cells on non-exposed surfaces were totally removed by the centrifugal force generated by the spinning disc.
  • EXAMPLE 3
  • HeLa cells grown and harvested as described above were introduced into the device of Example 2 into micro channels which contained moulded pillars of various dimensions dispersed in the channels so as to act as barriers to cell movement in the channels. A suspension of cell was introduced into the channels and the structure incubated for 18 hours to allow the cells to settle and grow. Subsequent examination revealed that in channels where the gaps between pillars were 10×60 μm or greater cells were observed to have moved freely past the barriers. In contrast where gaps between pillars were 10×20 μm or less, cells were prevented from passing the barrier when transported by liquid flow in suspension. However on subsequent incubation and growth cells were observed to migrate past such barriers by slow deformation. Such barrier structures may prove useful for study of cell movement or migration in response to chemical or physical stimuli. [0062]
  • EXAMPLE 4
  • HeLa cells transfected to yield stable expression of a Calreticulin-GFP fusion protein were introduced into a moulded apparatus of the type shown in FIG. 1, supporting channels of 100 μm width and 100 μm depth connected to circular chambers of 600 μm and 1000 μm diameter and 100 μm depth. Cells were incubated for 18 hours in a tissue culture incubator and examined by confocal fluorescence microscopy. Cells grown in microfabricated structures showed the same level of GFP expression as control cells grown under conventional tissue culture conditions. [0063]
  • EXAMPLE 5
  • HeLa cells were grown and introduced into a microfabricated disc as described in Example 1. Following incubation for 18 hours growth medium was removed from cells and replaced with media containing different concentrations of the membrane permeabilising agent digitonin in the range 0-0.2 mg/ml (w/v) and cells incubated in the presence of digitonin for 10 minutes. Thereafter the viability of the cells was measured as described in Example 1. Results were found to be equivalent to cells exposed to the same dose range of digitonin in a microtitre plate based assay. [0064]

Claims (19)

1. Apparatus microfabricated for performing cell growth and cell based assays in a liquid medium, said apparatus comprising:
a) a base plate supporting a plurality of micro-channel elements, each comprising a cell growth chamber, an inlet channel for supplying liquid sample thereto and an outlet channel for removal of liquid sample therefrom;
b) a cover plate positioned over said base plate said cover plate extending over said elements so as to define said chambers and connecting channels; said cover plate being supplied with holes to provide access to said channels; and
c) means, incorporated in said cell growth chambers, for cell attachment and cell growth.
2. Apparatus according to claim 1 wherein said base plate comprises a rotatable disc which is microfabricated to provide a sample introduction port located towards the centre of the disc and connected to an annular sample reservoir, and wherein said micro-channel elements are radially dispersed on said disc with their respective input channels connected to receive sample from said reservoir.
3. Apparatus according to claim 1 or claim 2 wherein said cover plate is fabricated from a gas permeable plastics material.
4. Apparatus according to any one of claims 1 to 3 wherein said means for cell attachment and cell growth comprises selectively treating or modifying at least a portion of a surface of said cell growth chamber.
5. Apparatus according to any one of claims 1 to 3 wherein means for cell attachment and cell growth comprises one or more microcarrier beads located in said cell growth chamber, wherein each of said microcarrier beads provides for cell attachment and cell growth.
6. Apparatus according to any one of claims 1 to 5 wherein the cell growth chamber further includes raised moulded features disposed on the base portion of the cell growth chamber to form pillars.
7. Apparatus according to any one of claims 1 to 6 wherein the cross-sectional area of said inlet channel is greater than that of said outlet channel.
8. Apparatus according to claim 7 wherein the cross-sectional area of said outlet channel is between 0.99 and 0.01 times that of said inlet channel.
9. Apparatus according to any one of claims 1 to 8 wherein at least some of said micro-channel elements each further comprises one or more assay chambers for performing assays involving cellular constituents and connected in line between said cell growth chamber and said outlet channel.
10. Apparatus according to claim 9 wherein the assay chamber or chambers are connected to each other and to said cell growth chamber by an intermediate channel or channels in the order of: inlet channel, cell growth chamber, intermediate channel 1, assay chamber 1, intermediate channel 2 (if present), assay chamber 2 (if present) . . . , outlet channel, and wherein the cross-sectional areas of the respective channels reduce progressively from the inlet channel to the outlet channel.
11. Apparatus according to claim 10 wherein the cross-sectional area of the or each intermediate channel and the outlet channel is between 0.99 and 0.01 times that of the immediately preceding (upstream) channel.
12. Apparatus according to any one of claims 1 to 11 wherein there is provided in or on an interior surface of one or more of said chambers a layer comprising a scintillant substance.
13. Apparatus according to claim 12 wherein the layer comprising a scintillant substance includes a binding moiety bound thereto, said binding moiety being a member of a specific binding pair selected from biotin, streptavidin, protein A, antibodies, lectins, hormone-receptors, nucleic acid probes, and DNA-binding proteins.
14. A method for determining the effect of a test substance on a cellular activity or physical parameter by the use of an apparatus as defined in claims 1-13, which method comprises:
a) providing a suspension of cells in a fluid medium;
b) introducing said cells into said apparatus and causing said cells to be transported to one or more cell growth chambers in said apparatus;
c) providing one or more samples of test substances whose effect upon the cells is to be measured under conditions so as to cause said cells to be exposed to said substances;
d) determining the effect of the test substances on said cells by means of optical detection.
15. A method according to claim 14 wherein cells are cultured adhering to a surface within the apparatus prior to the introduction of the test substances.
16. A method according to claims 14 or 15 wherein there are provided following step c) one or more assay reagents and dispersing said reagents to one or more reaction chambers in said apparatus.
17. A method according to claim 16 wherein at least one of said assay reagents is labelled with a detectable label selected from fluorescent labels, chemiluminescent labels, bioluminescent labels, enzyme labels and radioactive labels.
18. A method for measuring a cellular analyte by the use of the apparatus as defined in claims 1-13, which method comprises:
a) providing a suspension of cells containing an analyte to be measured in a fluid medium;
b) introducing said cells into said apparatus and causing the cells to be transported to one or more cell growth chambers in the apparatus;
c) allowing cells to grow;
d) providing one or more assay reagents and dispersing said reagents to one or more chambers in said apparatus;
e) measuring the cellular analyte by optical means.
19. A method according to claim 18 wherein at least one of said assay reagents is labelled with a detectable label selected from fluorescent labels, chemiluminescent labels, bioluminescent labels, enzyme labels and radioactive labels.
US10/650,412 1998-04-27 2003-08-28 Microfabricated apparatus for cell based assays Abandoned US20040058408A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/650,412 US20040058408A1 (en) 1998-04-27 2003-08-28 Microfabricated apparatus for cell based assays
US11/397,401 US7935522B2 (en) 1998-04-27 2006-04-04 Microfabricated apparatus for cell based assays
US12/236,120 US8030062B2 (en) 1998-04-27 2008-09-23 Microfabricated apparatus for cell based assays
US13/231,430 US20120003682A1 (en) 1998-04-27 2011-09-13 Microfabricated apparatus for cell based assays

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9808836.2 1998-04-27
GBGB9808836.2A GB9808836D0 (en) 1998-04-27 1998-04-27 Microfabricated apparatus for cell based assays
US09/673,169 US6632656B1 (en) 1998-04-27 1999-03-17 Microfabricated apparatus for cell based assays
US10/650,412 US20040058408A1 (en) 1998-04-27 2003-08-28 Microfabricated apparatus for cell based assays

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
PCT/GB1999/000954 Continuation WO1999055827A1 (en) 1998-04-27 1999-03-17 Microfabricated apparatus for cell based assays
US09/673,169 Continuation US6632656B1 (en) 1998-04-27 1999-03-17 Microfabricated apparatus for cell based assays
US09673169 Continuation 1999-03-17

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/397,401 Continuation US7935522B2 (en) 1998-04-27 2006-04-04 Microfabricated apparatus for cell based assays
US12/236,120 Continuation US8030062B2 (en) 1998-04-27 2008-09-23 Microfabricated apparatus for cell based assays

Publications (1)

Publication Number Publication Date
US20040058408A1 true US20040058408A1 (en) 2004-03-25

Family

ID=10830968

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/673,169 Expired - Lifetime US6632656B1 (en) 1998-04-27 1999-03-17 Microfabricated apparatus for cell based assays
US10/650,412 Abandoned US20040058408A1 (en) 1998-04-27 2003-08-28 Microfabricated apparatus for cell based assays
US11/397,401 Expired - Lifetime US7935522B2 (en) 1998-04-27 2006-04-04 Microfabricated apparatus for cell based assays
US12/236,120 Expired - Fee Related US8030062B2 (en) 1998-04-27 2008-09-23 Microfabricated apparatus for cell based assays
US13/231,430 Abandoned US20120003682A1 (en) 1998-04-27 2011-09-13 Microfabricated apparatus for cell based assays

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/673,169 Expired - Lifetime US6632656B1 (en) 1998-04-27 1999-03-17 Microfabricated apparatus for cell based assays

Family Applications After (3)

Application Number Title Priority Date Filing Date
US11/397,401 Expired - Lifetime US7935522B2 (en) 1998-04-27 2006-04-04 Microfabricated apparatus for cell based assays
US12/236,120 Expired - Fee Related US8030062B2 (en) 1998-04-27 2008-09-23 Microfabricated apparatus for cell based assays
US13/231,430 Abandoned US20120003682A1 (en) 1998-04-27 2011-09-13 Microfabricated apparatus for cell based assays

Country Status (10)

Country Link
US (5) US6632656B1 (en)
EP (2) EP1298198B1 (en)
JP (1) JP4064631B2 (en)
AT (2) ATE342347T1 (en)
CA (1) CA2330034A1 (en)
DE (2) DE69909462T2 (en)
DK (1) DK1073709T3 (en)
ES (1) ES2203098T3 (en)
GB (1) GB9808836D0 (en)
WO (1) WO1999055827A1 (en)

Cited By (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020125135A1 (en) * 1999-12-23 2002-09-12 Helene Derand Microfluidic surfaces
US20030077817A1 (en) * 2001-04-10 2003-04-24 Zarur Andrey J. Microfermentor device and cell based screening method
US20030129360A1 (en) * 2001-12-31 2003-07-10 Helene Derand Microfluidic device and its manufacture
US20030143114A1 (en) * 1998-12-30 2003-07-31 Per Andersson Microanalysis device
US20030156763A1 (en) * 2001-12-31 2003-08-21 Gyros Ab. Method and arrangement for reducing noise
US20030173650A1 (en) * 2000-05-12 2003-09-18 Olle Larsson Micro channel in a substrate
US20030211012A1 (en) * 2002-03-31 2003-11-13 Marten Bergstrom Efficient microfluidic devices
US20040058407A1 (en) * 2001-04-10 2004-03-25 Miller Scott E. Reactor systems having a light-interacting component
US20040058437A1 (en) * 2001-04-10 2004-03-25 Rodgers Seth T. Materials and reactor systems having humidity and gas control
US20040067051A1 (en) * 2000-11-23 2004-04-08 Gunnar Kylberg Device and method for the controlled heating in micro channel systems
US20040121454A1 (en) * 2000-03-10 2004-06-24 Bioprocessors Corp. Microreactor
US20040132166A1 (en) * 2001-04-10 2004-07-08 Bioprocessors Corp. Determination and/or control of reactor environmental conditions
US20050026134A1 (en) * 2002-04-10 2005-02-03 Bioprocessors Corp. Systems and methods for control of pH and other reactor environment conditions
US20050026273A1 (en) * 2003-06-05 2005-02-03 Zarur Andrey J. Reactor with memory component
US20050032204A1 (en) * 2001-04-10 2005-02-10 Bioprocessors Corp. Microreactor architecture and methods
US20050054101A1 (en) * 2003-07-17 2005-03-10 Global Cell Solutions Llc Automated cell culture system and process
US20050106714A1 (en) * 2002-06-05 2005-05-19 Zarur Andrey J. Rotatable reactor systems and methods
US20050141344A1 (en) * 2003-10-03 2005-06-30 Gyros Ab Liquid router
US20050153433A1 (en) * 2001-08-28 2005-07-14 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20050179901A1 (en) * 2002-05-31 2005-08-18 Gyros Ab Detector arrangement based on surfaces plasmon resonance
US20050186685A1 (en) * 2004-01-17 2005-08-25 Gyros Ab Protecting agent
US20050214442A1 (en) * 2001-11-27 2005-09-29 Anders Larsson Surface and its manufacture and uses
US6955738B2 (en) 2002-04-09 2005-10-18 Gyros Ab Microfluidic devices with new inner surfaces
US6967101B1 (en) 1999-03-24 2005-11-22 Gyros Ab Surface and its manufacture and uses
US20050271560A1 (en) * 2004-06-07 2005-12-08 Bioprocessors Corp. Gas control in a reactor
US20050277195A1 (en) * 2002-04-30 2005-12-15 Gyros Ab Integrated microfluidic device (ea)
US20050277187A1 (en) * 2004-06-07 2005-12-15 Bioprocessors Corp. Creation of shear in a reactor
US20050279925A1 (en) * 2001-03-19 2005-12-22 Per Andersson Microfluidic system
US20050287673A1 (en) * 2004-06-07 2005-12-29 Bioprocessors Corp. Reactor mixing
US20060019333A1 (en) * 2004-06-07 2006-01-26 Rodgers Seth T Control of reactor environmental conditions
US20060110294A1 (en) * 2003-01-30 2006-05-25 Gyros Patent Ab Inner walls of microfluidic devices
US20060194273A1 (en) * 1998-04-27 2006-08-31 Gyros Patent Ab Microfabricated apparatus for cell based assays
US7104517B1 (en) 1999-06-30 2006-09-12 Gyros Patent Ab Polymer valves
US20060246526A1 (en) * 2003-06-02 2006-11-02 Gyros Patent Ab Microfluidic affinity assays with improved performance
US20060250923A1 (en) * 2005-05-09 2006-11-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for fluid mediated disk activation and deactivation
US20060253692A1 (en) * 2005-05-09 2006-11-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use memory device with associated information
US20060268661A1 (en) * 2005-05-09 2006-11-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluid mediated disk activation and deactivation mechanisms
US20060279874A1 (en) * 2005-06-09 2006-12-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for rotational control of data storage devices
US20060280088A1 (en) * 2005-06-09 2006-12-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Rotation responsive disk activation and deactivation mechanisms
US20070002708A1 (en) * 2005-05-09 2007-01-04 Searete, Llc, A Limited Liability Corporation Of The State Of Delaware Rotation responsive disk activation and deactivation mechanisms
US20070033352A1 (en) * 2005-05-09 2007-02-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use data storing device
US20070041231A1 (en) * 2005-08-05 2007-02-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Memory device activation and deactivation
US20070054270A1 (en) * 2003-03-23 2007-03-08 Gyros Patent Ab Preloaded microfluidic devices
US20070058450A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use data storing device
US20070058505A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Data retrieval systems
US20070061370A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Data retrieval methods
US20070070868A1 (en) * 2005-05-09 2007-03-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluid mediated disk activation and deactivation mechanisms
US20070134739A1 (en) * 2005-12-12 2007-06-14 Gyros Patent Ab Microfluidic assays and microfluidic devices
EP1815244A1 (en) * 2004-11-11 2007-08-08 Agency for Science, Technology and Research Cell culture device
US20070241061A1 (en) * 2004-01-29 2007-10-18 Johan Engstrom Flow Paths Comprising One or Two Porous Beds
US20070253316A1 (en) * 2005-05-09 2007-11-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method of manufacturing a limited use data storing device
US20070259109A1 (en) * 2004-01-02 2007-11-08 Gyros Patent Ab Large Scale Surface Modification of Microfluidic Devices
US20080233594A1 (en) * 2005-01-17 2008-09-25 Gyros Patent Ab Method For Detecting An At Least Bivalent Analyte Using Two Affinity Reactants
US7429354B2 (en) 2001-03-19 2008-09-30 Gyros Patent Ab Structural units that define fluidic functions
US20090010819A1 (en) * 2004-01-17 2009-01-08 Gyros Patent Ab Versatile flow path
US20090022023A1 (en) * 2006-06-20 2009-01-22 Searete Llc Rotation responsive disk activation and deactivation mechanisms
US20090035793A1 (en) * 2005-08-31 2009-02-05 Nissan Chemical Industries, Ltd. Microchip for cell response evaluation
US20090050620A1 (en) * 2004-01-06 2009-02-26 Gyros Ab Contact heating arrangement
US20090122666A1 (en) * 2005-08-05 2009-05-14 Searete Llc Limited use memory device with associated information
US20090137018A1 (en) * 2003-06-30 2009-05-28 University Of South Florida Magnetic three-dimensional cell culture apparatus and method
US7553393B2 (en) 2000-01-30 2009-06-30 Gyros Ab Method for covering a microfluidic assembly
US20090305397A1 (en) * 2005-03-16 2009-12-10 John Robert Dodgson Cellular entity maturation and transportation systems
US20100151594A1 (en) * 2003-03-23 2010-06-17 Inganaes Mats Collection of micro scale devices
US20100167355A1 (en) * 2008-12-29 2010-07-01 Stmicroelectronics S.R.L. Microreactor with vent channels for removing air from a reaction chamber
US7833486B2 (en) 2003-05-23 2010-11-16 Gyros Patent Ab Hydrophilic/hydrophobic surfaces
US20110002207A1 (en) * 2006-06-19 2011-01-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for fluid mediated disk activation and deactivation
US7916592B2 (en) 2005-05-09 2011-03-29 The Invention Science Fund I, Llc Fluid mediated disk activation and deactivation mechanisms
US20110189056A1 (en) * 2007-10-11 2011-08-04 Accelbeam Devices, Llc Microwave reactor
US20110236924A1 (en) * 2008-12-19 2011-09-29 Halverson Kurt J System and method for processing samples
US8121016B2 (en) 2005-05-09 2012-02-21 The Invention Science Fund I, Llc Rotation responsive disk activation and deactivation mechanisms
US8220014B2 (en) 2005-05-09 2012-07-10 The Invention Science Fund I, Llc Modifiable memory devices having limited expected lifetime
US8218262B2 (en) 2005-05-09 2012-07-10 The Invention Science Fund I, Llc Method of manufacturing a limited use data storing device including structured data and primary and secondary read-support information
US8264928B2 (en) 2006-06-19 2012-09-11 The Invention Science Fund I, Llc Method and system for fluid mediated disk activation and deactivation
US20120264654A1 (en) * 2009-12-28 2012-10-18 Dhananjaya Dendukuri Diagnostic element, and a diagnostic device comprising a diagnostic element
US8389277B2 (en) 2007-10-11 2013-03-05 Agency For Science, Technology And Research Forming cell structure with transient linker in cage
US8462605B2 (en) 2005-05-09 2013-06-11 The Invention Science Fund I, Llc Method of manufacturing a limited use data storing device
US8535945B2 (en) 2008-12-19 2013-09-17 3M Innovative Properties Company System and method for concentrating samples
CN103323605A (en) * 2013-06-18 2013-09-25 杭州普施康生物科技有限公司 Micro-fluidic chip for glycosylated hemoglobin immunodetection
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US8722421B2 (en) 1998-05-08 2014-05-13 Gyros Patent Ab Microfluidic device
CN104502617A (en) * 2014-12-24 2015-04-08 杭州霆科生物科技有限公司 Full-automatic and high-throughput micro-fluidic chip system and method for detecting pesticide residue
US9470612B2 (en) 2011-06-30 2016-10-18 3M Innovative Properties Company Systems and methods for detecting an analyte of interest in a sample using filters and microstructured surfaces
US9476025B2 (en) 2003-07-23 2016-10-25 University Of South Florida Ferromagnetic cell and tissue culture microcarriers
US9488563B2 (en) 2011-06-30 2016-11-08 3M Innovative Properties Company Systems and methods for detecting an analyte of interest in a sample using microstructured surfaces
US20170336399A1 (en) * 2014-11-14 2017-11-23 Yale University Novel methods and devices for high-throughput quantification, detection and temporal profiling of cellular secretions, and compositions identified using same
US10408821B2 (en) * 2016-04-14 2019-09-10 Triad National Security, Llc Microfluidic aspirator and methods of making and using the same
US10519410B2 (en) 2015-08-26 2019-12-31 Emulate, Inc Pressure manifold and culture module
US10620194B2 (en) 2001-03-19 2020-04-14 Gyros Patent Ab Characterization of reaction variables
CN113155588A (en) * 2021-05-13 2021-07-23 武汉新烽光电股份有限公司 Rapid automatic water quality detection system and method based on micro-fluidic
US11287358B1 (en) 2016-04-14 2022-03-29 Triad National Security, Llc Microfluidic aspirator and multi-purpose flow sensor and methods of making and using the same

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912641D0 (en) * 1999-05-28 1999-07-28 Ashby Scient Ltd Textured and porous silicone rubber
US7560274B1 (en) 1999-05-28 2009-07-14 Cellon S.A. Culture chamber
GB2355717A (en) 1999-10-28 2001-05-02 Amersham Pharm Biotech Uk Ltd DNA isolation method
US6818435B2 (en) * 2000-05-15 2004-11-16 Tecan Trading Ag Microfluidics devices and methods for performing cell based assays
US6720187B2 (en) 2000-06-28 2004-04-13 3M Innovative Properties Company Multi-format sample processing devices
US6734401B2 (en) 2000-06-28 2004-05-11 3M Innovative Properties Company Enhanced sample processing devices, systems and methods
US6627159B1 (en) 2000-06-28 2003-09-30 3M Innovative Properties Company Centrifugal filling of sample processing devices
WO2002092783A2 (en) * 2001-05-15 2002-11-21 Children's Medical Center Corporation Methods and apparatus for application of micro-mechanical forces to tissues
US7326385B2 (en) 2001-05-30 2008-02-05 Biolex Therapeutics, Inc. Plate and method for high throughput screening
EP1483052B1 (en) 2001-08-28 2010-12-22 Gyros Patent Ab Retaining microfluidic microcavity and other microfluidic structures
ATE477054T1 (en) 2001-09-17 2010-08-15 Gyros Patent Ab FUNCTIONAL UNIT ALLOWING CONTROLLED FLOW IN A MICROFLUID DEVICE
KR100442836B1 (en) * 2001-11-10 2004-08-02 삼성전자주식회사 System and method for circulating biochemical fluidic solutions around closed two or more temperature zones of chambers
US6889468B2 (en) 2001-12-28 2005-05-10 3M Innovative Properties Company Modular systems and methods for using sample processing devices
JP2003225083A (en) * 2002-02-05 2003-08-12 Sony Corp Disc-shaped culturing medium
GB0206117D0 (en) * 2002-03-15 2002-04-24 Imaging Res Solutions Ltd Use of microfabricated devices
EP2666849A3 (en) * 2002-04-01 2014-05-28 Fluidigm Corporation Microfluidic particle-analysis systems
FR2842747B1 (en) * 2002-07-23 2004-10-15 Commissariat Energie Atomique METHOD AND DEVICE FOR SCREENING MOLECULES IN CELLS
EP1539919A4 (en) * 2002-08-27 2007-07-04 Univ Vanderbilt Bioreactors with an array of chambers and a common feed line
US7332129B2 (en) 2003-01-09 2008-02-19 3M Innovative Properties Company Sample processing device having process chambers with bypass slots
WO2004065618A2 (en) * 2003-01-16 2004-08-05 Thermogenic Imaging Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers
US7413891B2 (en) * 2003-04-30 2008-08-19 Biovitesse, Inc. Apparatus and method for detecting live cells with an integrated filter and growth detection device
GB2401612A (en) * 2003-05-13 2004-11-17 Univ Manchester Method and device for culturing tissue
CA2522410A1 (en) * 2003-05-19 2004-11-25 Japan Science And Technology Agency Micro chamber for cell culture
US20050042770A1 (en) * 2003-05-23 2005-02-24 Gyros Ab Fluidic functions based on non-wettable surfaces
FR2857451B1 (en) * 2003-07-11 2005-09-30 Commissariat Energie Atomique METHOD AND DEVICE FOR ANALYSIS OF LIVE REACTION ENVIRONMENTS
EP1508373A3 (en) * 2003-08-19 2005-08-03 Herbener, Heinz-Gerd Sample carrier with channel for liquids
US7582472B2 (en) * 2003-08-26 2009-09-01 Smith Kenneth E Apparatus and method for liquid sample testing
EP2259050A3 (en) * 2003-08-26 2010-12-22 Blueshift Biotechnologies, Inc. Time dependent fluorescence measurements
US7276351B2 (en) 2003-09-10 2007-10-02 Seahorse Bioscience Method and device for measuring multiple physiological properties of cells
US8658349B2 (en) 2006-07-13 2014-02-25 Seahorse Bioscience Cell analysis apparatus and method
US7407799B2 (en) 2004-01-16 2008-08-05 California Institute Of Technology Microfluidic chemostat
US20050164373A1 (en) * 2004-01-22 2005-07-28 Oldham Mark F. Diffusion-aided loading system for microfluidic devices
WO2005081801A2 (en) * 2004-02-09 2005-09-09 Blueshift Biotechnologies, Inc. Methods and apparatus for scanning small sample volumes
JP2005257337A (en) * 2004-03-09 2005-09-22 Brother Ind Ltd Inspection object receiver, inspection device, and inspection method
US8058056B2 (en) 2004-03-12 2011-11-15 The Regents Of The University Of California Method and apparatus for integrated cell handling and measurements
US20050227350A1 (en) * 2004-04-13 2005-10-13 Agency For Science, Technology And Research Device and method for studying cell migration and deformation
JP2008505321A (en) 2004-07-02 2008-02-21 ブルーシフト・バイオテクノロジーズ・インコーポレーテッド Search for phosphor microenvironment
WO2006110098A1 (en) 2005-04-14 2006-10-19 Gyros Patent Ab Meander
US7947235B2 (en) 2005-04-14 2011-05-24 Gyros Ab Microfluidic device with finger valves
US20070014695A1 (en) * 2005-04-26 2007-01-18 Applera Corporation Systems and Methods for Multiple Analyte Detection
US7754474B2 (en) 2005-07-05 2010-07-13 3M Innovative Properties Company Sample processing device compression systems and methods
US7323660B2 (en) 2005-07-05 2008-01-29 3M Innovative Properties Company Modular sample processing apparatus kits and modules
US7763210B2 (en) 2005-07-05 2010-07-27 3M Innovative Properties Company Compliant microfluidic sample processing disks
US8449837B2 (en) * 2005-10-11 2013-05-28 The Johns Hopkins University Microfluidic device for high-throughput cellular gradient and dose response studies
US8822206B2 (en) * 2005-10-11 2014-09-02 The Johns Hopkins University Device for high-throughput stimulation, immunostaining, and visualization of single cells
US8293524B2 (en) 2006-03-31 2012-10-23 Fluxion Biosciences Inc. Methods and apparatus for the manipulation of particle suspensions and testing thereof
DK2772535T3 (en) 2006-05-31 2022-07-04 Childrens Medical Center ABC5-positive mesenchymal stem cells as immune modulators
US7998418B1 (en) 2006-06-01 2011-08-16 Nanotek, Llc Evaporator and concentrator in reactor and loading system
US7641860B2 (en) 2006-06-01 2010-01-05 Nanotek, Llc Modular and reconfigurable multi-stage microreactor cartridge apparatus
KR101335920B1 (en) * 2006-08-02 2013-12-03 삼성전자주식회사 Thin film chemical analysis apparatus and analysis method using the same
US7854902B2 (en) * 2006-08-23 2010-12-21 Nanotek, Llc Modular and reconfigurable multi-stage high temperature microreactor cartridge apparatus and system for using same
WO2008118808A1 (en) 2007-03-23 2008-10-02 Advion Bioscience, Inc. Liquid chromatography-mass spectrometry
DK2644205T3 (en) 2007-04-12 2018-09-24 Brigham & Womens Hospital Inc Targeting ABCB5 for Cancer Therapy
JP2010525873A (en) * 2007-05-01 2010-07-29 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド Wound healing device
JP4932656B2 (en) * 2007-09-28 2012-05-16 富士フイルム株式会社 Micro chemical equipment
JP2009106169A (en) * 2007-10-26 2009-05-21 Univ Soka Cell culturing method using microchamber array and cell culturing apparatus therefor
EP2214801A4 (en) * 2007-11-22 2016-12-21 Samsung Electronics Co Ltd Thin film valve device and its controlling apparatus
DE102008010436A1 (en) * 2008-02-21 2009-09-03 Berthold Technologies Gmbh & Co. Kg Apparatus and method for measuring luminescence and fluorescence of transfected cells or organ parts
EP2730644A3 (en) * 2008-06-04 2014-10-22 TissUse GmbH Organ-on-a-chip-device
FR2937050A1 (en) * 2008-10-10 2010-04-16 Inst Curie CELL CULTURE DEVICE
US8202702B2 (en) 2008-10-14 2012-06-19 Seahorse Bioscience Method and device for measuring extracellular acidification and oxygen consumption rate with higher precision
WO2010078623A1 (en) * 2009-01-07 2010-07-15 The University Of Queensland Cell migration
DE102009039956A1 (en) * 2009-08-27 2011-03-10 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Microfluidic system and method for its production
US8834792B2 (en) 2009-11-13 2014-09-16 3M Innovative Properties Company Systems for processing sample processing devices
US20110195401A1 (en) * 2010-02-10 2011-08-11 Selinfreund Richard H Systems and methods for determining food allergies
KR20130032895A (en) 2010-06-17 2013-04-02 아박시스, 인크. Rotors for immunoassays
EP2404867A1 (en) * 2010-07-09 2012-01-11 Trinean NV Method for preparing microfluidic devices
US9182353B2 (en) 2010-07-22 2015-11-10 Hach Company Lab-on-a-chip for alkalinity analysis
WO2014081840A1 (en) * 2012-11-21 2014-05-30 Vanderbilt University Organ on chip integration and applications of the same
US20130287613A1 (en) 2010-10-07 2013-10-31 Vanderbilt University Peristaltic micropump and related systems and methods
MX337943B (en) 2011-05-18 2016-03-29 Focus Diagnostics Inc Systems and methods for detecting the presence of a selected volume of material in a sample processing device.
JP2014517291A (en) 2011-05-18 2014-07-17 スリーエム イノベイティブ プロパティズ カンパニー System and method for valve operation of a sample processing apparatus
AU2012255144B2 (en) 2011-05-18 2015-01-29 Diasorin Italia S.P.A. Systems and methods for volumetric metering on a sample processing device
DE102011076543B4 (en) * 2011-05-26 2014-04-10 Siemens Aktiengesellschaft CT system with a quantum-counting X-ray detector
US10209241B2 (en) * 2011-08-12 2019-02-19 Rutgers, The State University Of New Jersey High throughput sensitization detection devices and methods
KR101257700B1 (en) * 2011-12-05 2013-04-24 삼성전자주식회사 Microfluidic device and microfluidic system including thereof
GB201121959D0 (en) * 2011-12-21 2012-02-01 Univ Leeds Assay of functional cell viability
TWI456196B (en) 2012-04-24 2014-10-11 Ind Tech Res Inst Immunoassay test apparatus
US9180449B2 (en) 2012-06-12 2015-11-10 Hach Company Mobile water analysis
EP2872633A4 (en) * 2012-07-13 2016-03-09 Jordan L Holtzman Cellular and animal models for screening therapeutic agents for the treatment of alzheimer's disease
TWI475226B (en) * 2012-08-01 2015-03-01 Univ Feng Chia The apparatus and methodology to carry out biochemical testing on a centrifugal platform using flow splitting techniques
US9573128B1 (en) * 2012-09-06 2017-02-21 SciKon Innovation, Inc. Fluidics device allowing fluid flow between a plurality of wells
US9518977B2 (en) 2012-10-19 2016-12-13 University Of Washington Through Its Center For Commercialization Microfluidic assay apparatus and methods of use
CN102921480B (en) * 2012-10-26 2014-10-01 北京理工大学 Method for manufacturing micro-fluidic chip by ultraviolet cured optical cement
US9494577B2 (en) 2012-11-13 2016-11-15 Seahorse Biosciences Apparatus and methods for three-dimensional tissue measurements based on controlled media flow
USD768872S1 (en) 2012-12-12 2016-10-11 Hach Company Cuvette for a water analysis instrument
EP2961825A4 (en) * 2013-02-26 2016-11-16 Ddnt Consultants Australia Pty Ltd Structure for culturing cells
JP6235115B2 (en) 2013-03-11 2017-11-22 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Bacteria detection cartridge
WO2015009688A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University Microfluidic chip for analysis of cell motility and methods for using same
WO2015187717A1 (en) 2014-06-02 2015-12-10 Seahorse Bioscience Single column microplate system and carrier for analysis of biological samples
JP5994116B2 (en) * 2014-08-26 2016-09-21 ローム株式会社 Rotary analysis chip and measurement system
US10035145B2 (en) 2014-12-02 2018-07-31 SciKon Innovation, Inc. Piston assembly and related systems for use with a fluidics device
US9993819B2 (en) 2014-12-30 2018-06-12 Stmicroelectronics S.R.L. Apparatus for actuating and reading a centrifugal microfluidic disk for biological and biochemical analyses, and use of the apparatus
EP3243899A4 (en) * 2015-01-06 2018-09-12 Droguett Bizet, Sara Apparatus for installing a system such as a lab-on-a-chip for identifying antibiotic susceptibility at the point of care of the patients
JP2018512171A (en) 2015-03-23 2018-05-17 シコン イノベーション,インク. Methods and associated systems for use with fluidic devices
US20180080925A1 (en) * 2015-04-01 2018-03-22 President And Fellows Of Harvard College Respiration device for analysis of a response to shear stress and foreign agents on cells
WO2016161081A1 (en) 2015-04-03 2016-10-06 Fluxion Biosciences, Inc. Molecular characterization of single cells and cell populations for non-invasive diagnostics
US9757728B2 (en) * 2016-01-26 2017-09-12 Lidong Qin Microfluidic aliquoting for single-cell isolation
SE540775C2 (en) * 2016-03-21 2018-11-06 Microfluidic device for culturing cells
CN108732339B (en) 2017-04-19 2021-04-13 光宝电子(广州)有限公司 Flow channel device for multiple reaction biological detection and detection method thereof
DE102017209942B4 (en) * 2017-06-13 2019-05-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Device and method for the cultivation of cells
CN108043478A (en) * 2017-12-04 2018-05-18 国家纳米科学中心 A kind of micro-fluidic chip, manual centrifugal device and nucleic acid detection method
KR102401909B1 (en) * 2018-08-30 2022-05-24 주식회사 엘지화학 A high-speed screening analysis system for reaction optimization
WO2020084099A1 (en) * 2018-10-24 2020-04-30 Danmarks Tekniske Universitet Multi function spinning platform
EP4023741A4 (en) 2019-08-29 2023-11-08 Fanuc Corporation Cell production device and cell production method
KR20210053010A (en) * 2019-11-01 2021-05-11 주식회사라이브셀인스트루먼트 Disk for cell distribution and culture, real-time monitoring system, and method for distribution and culture of cells
EP4191251A1 (en) * 2020-07-29 2023-06-07 Kyocera Corporation Flow path device
DE102022201938A1 (en) 2022-02-24 2023-08-24 Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. Fluid transfer between rotating modules

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2003A (en) * 1841-03-12 Improvement in horizontal windivhlls
US2002A (en) * 1841-03-12 Tor and planter for plowing
US2005A (en) * 1841-03-16 Improvement in the manner of constructing molds for casting butt-hinges
US2006A (en) * 1841-03-16 Clamp for crimping leather
US4018652A (en) * 1976-01-09 1977-04-19 Mcdonnell Douglas Corporation Process and apparatus for ascertaining the concentration of microorganism in a water specimen
US4077845A (en) * 1977-04-20 1978-03-07 Miles Laboratories, Inc. Disposable inoculation device and process of using same
US4318994A (en) * 1979-08-30 1982-03-09 Mcdonnell Douglas Corporation Enterobacteriaceae species biochemical test card
US4440638A (en) * 1982-02-16 1984-04-03 U.T. Board Of Regents Surface field-effect device for manipulation of charged species
US4661451A (en) * 1984-02-06 1987-04-28 Ortho Diagnostic Systems, Inc. Methods for immobilizing and translocating biological cells
US4868129A (en) * 1987-08-27 1989-09-19 Biotrack Inc. Apparatus and method for dilution and mixing of liquid samples
US4946795A (en) * 1987-08-27 1990-08-07 Biotrack, Inc. Apparatus and method for dilution and mixing of liquid samples
US5190879A (en) * 1990-05-08 1993-03-02 Bowolfe, Inc. Controlled environment animal isolation systems
US5230866A (en) * 1991-03-01 1993-07-27 Biotrack, Inc. Capillary stop-flow junction having improved stability against accidental fluid flow
US5593838A (en) * 1994-11-10 1997-01-14 David Sarnoff Research Center, Inc. Partitioned microelectronic device array
US5637469A (en) * 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems
US5650334A (en) * 1995-08-31 1997-07-22 First Medical, Inc. Fluorescent labelling compositions and methods for their use
US5653939A (en) * 1991-11-19 1997-08-05 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection
US5660993A (en) * 1993-02-18 1997-08-26 Biocircuits Corporation Disposable device in diagnostic assays
US5800778A (en) * 1995-05-31 1998-09-01 Biomerieux Vitek, Inc. Sealant for sample holder
US6143247A (en) * 1996-12-20 2000-11-07 Gamera Bioscience Inc. Affinity binding-based system for detecting particulates in a fluid
US6143248A (en) * 1996-08-12 2000-11-07 Gamera Bioscience Corp. Capillary microvalve
US6296020B1 (en) * 1998-10-13 2001-10-02 Biomicro Systems, Inc. Fluid circuit components based upon passive fluid dynamics
US6299839B1 (en) * 1995-08-31 2001-10-09 First Medical, Inc. System and methods for performing rotor assays
US6319469B1 (en) * 1995-12-18 2001-11-20 Silicon Valley Bank Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
US6499499B2 (en) * 2001-04-20 2002-12-31 Nanostream, Inc. Flow control in multi-stream microfluidic devices
US6591852B1 (en) * 1998-10-13 2003-07-15 Biomicro Systems, Inc. Fluid circuit components based upon passive fluid dynamics
US6967101B1 (en) * 1999-03-24 2005-11-22 Gyros Ab Surface and its manufacture and uses
US6985672B2 (en) * 2000-11-23 2006-01-10 Gyros Ab Device and method for the controlled heating in micro channel systems

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679367A (en) 1970-09-14 1972-07-25 Technicon Instr Apparatus for determining the pack volume of particulates in liquid mixtures
US3728644A (en) * 1971-11-01 1973-04-17 Bell Telephone Labor Inc Polarization transformation apparatus
US3899296A (en) * 1974-07-17 1975-08-12 Us Energy Whole blood analysis rotor for a multistation dynamic photometer
US4006749A (en) * 1975-01-31 1977-02-08 Consolidated Cigar Corporation Removal of harmful components from tobacco smoke
FR2400700A1 (en) 1977-08-18 1979-03-16 Guigan Jean CONDITIONING DEVICE FOR A LIQUID SAMPLE FOR ANALYSIS
US4381291A (en) 1979-02-23 1983-04-26 Ab Fortia Measurement of free ligands
DE3044385A1 (en) 1980-11-25 1982-06-24 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR CARRYING OUT ANALYTICAL PROVISIONS AND ROTOR INSERT ELEMENT SUITABLE FOR THIS
US4426451A (en) 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4729862A (en) 1981-04-24 1988-03-08 Allied-Signal Inc. Nylon composition for use in rotational molding
DE3314961A1 (en) 1983-04-25 1984-10-25 Boehringer Mannheim Gmbh, 6800 Mannheim ANALYZER FOR PHOTOMETRICALLY DETERMINING A PARAMETER OF A LIQUID
GB8317124D0 (en) 1983-06-23 1983-07-27 Ekins R P Free ligand assay
US4676274A (en) 1985-02-28 1987-06-30 Brown James F Capillary flow control
US4756884A (en) 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
DK112986D0 (en) 1986-03-11 1986-03-11 Svenska Sockerfabriks Ab PROCEDURE FOR THE DETECTION OF COMPONENTS IN A TEST
WO1988001058A1 (en) 1986-08-06 1988-02-11 Roger Philip Ekins Determination of analyte concentration using two labelling markers
US4935346A (en) 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US4762683A (en) 1986-09-16 1988-08-09 E. I. Du Pont De Nemours And Company Analysis device
US4806316A (en) 1987-03-17 1989-02-21 Becton, Dickinson And Company Disposable device for use in chemical, immunochemical and microorganism analysis
US4940527A (en) 1987-06-01 1990-07-10 Abbott Laboratories Two-part test cartridge for centrifuge
US5242803A (en) 1987-07-17 1993-09-07 Martin Marietta Energy Systems, Inc. Rotor assembly and assay method
US5173262A (en) 1987-07-17 1992-12-22 Martin Marietta Energy Systems, Inc. Rotor assembly and method for automatically processing liquids
US4839292B1 (en) * 1987-09-11 1994-09-13 Joseph G Cremonese Cell culture flask utilizing membrane barrier
US5252294A (en) 1988-06-01 1993-10-12 Messerschmitt-Bolkow-Blohm Gmbh Micromechanical structure
US5160702A (en) 1989-01-17 1992-11-03 Molecular Devices Corporation Analyzer with improved rotor structure
US5006749A (en) 1989-10-03 1991-04-09 Regents Of The University Of California Method and apparatus for using ultrasonic energy for moving microminiature elements
FR2657879B1 (en) * 1990-02-02 1994-09-02 Imedex CELL CULTURE PLATE.
SE470347B (en) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Microstructure for fluid flow systems and process for manufacturing such a system
US5122284A (en) 1990-06-04 1992-06-16 Abaxis, Inc. Apparatus and method for optically analyzing biological fluids
US5413732A (en) 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
AU4047493A (en) 1992-04-02 1993-11-08 Abaxis, Inc. Analytical rotor with dye mixing chamber
US5744366A (en) 1992-05-01 1998-04-28 Trustees Of The University Of Pennsylvania Mesoscale devices and methods for analysis of motile cells
US5587128A (en) 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
AU674685B2 (en) 1992-05-01 1997-01-09 Trustees Of The University Of Pennsylvania, The Fluid handling in microfabricated analytical devices
US5304487A (en) 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US6156270A (en) 1992-05-21 2000-12-05 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5798215A (en) 1993-02-18 1998-08-25 Biocircuits Corporation Device for use in analyte detection assays
SE508435C2 (en) 1993-02-23 1998-10-05 Erik Stemme Diaphragm pump type pump
WO1994026413A1 (en) * 1993-05-17 1994-11-24 Amersham International Plc Devices and methods for the measurement of cellular biochemical processes
SE501380C2 (en) 1993-06-15 1995-01-30 Pharmacia Lkb Biotech Ways to manufacture microchannel / microcavity structures
US5432009A (en) 1993-06-17 1995-07-11 Sekisui Kagaku Kogyo Kabushiki Kaisha Film for first-aid sticking plaster
US5368704A (en) 1993-08-06 1994-11-29 Teknekron Corporation Micro-electrochemical valves and method
US5409665A (en) 1993-09-01 1995-04-25 Abaxis, Inc. Simultaneous cuvette filling with means to isolate cuvettes
SE9304145D0 (en) 1993-12-10 1993-12-10 Pharmacia Lkb Biotech Ways to manufacture cavity structures
DE4400955C2 (en) 1993-12-23 1999-04-01 Fraunhofer Ges Forschung Adhesion-controllable surface structure
SE9401327D0 (en) 1994-04-20 1994-04-20 Pharmacia Lkb Biotech Hydrophilization of hydrophobic polymer
US5627041A (en) 1994-09-02 1997-05-06 Biometric Imaging, Inc. Disposable cartridge for an assay of a biological sample
DE29500587U1 (en) * 1995-01-17 1996-05-15 Schreiber Hans Kit especially for blood group determination
EP0823054A1 (en) 1995-04-27 1998-02-11 Pharmacia Biotech AB Apparatus for continuously measuring physical and chemical parameters in a fluid flow
US5609828A (en) 1995-05-31 1997-03-11 bio M erieux Vitek, Inc. Sample card
SE9502251D0 (en) 1995-06-21 1995-06-21 Pharmacia Ab Flow-through sampling cell and use thereof
SE9502258D0 (en) 1995-06-21 1995-06-21 Pharmacia Biotech Ab Method for the manufacture of a membrane-containing microstructure
US20020025583A1 (en) 1995-08-31 2002-02-28 Stoughton L. Ellsworth Analytical rotor and method for detecting analytes in liquid samples
US6130098A (en) 1995-09-15 2000-10-10 The Regents Of The University Of Michigan Moving microdroplets
AU702403B2 (en) * 1995-12-05 1999-02-18 Gamera Bioscience Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system with on-board informatics
US5698162A (en) 1996-02-27 1997-12-16 Johnson & Johnson Clinical Diagnostics Apparatus for staining of cells and tissues
US6144447A (en) 1996-04-25 2000-11-07 Pharmacia Biotech Ab Apparatus for continuously measuring physical and chemical parameters in a fluid flow
SE9602638D0 (en) 1996-07-03 1996-07-03 Pharmacia Biotech Ab An improved method for the capillary electrophoresis of nucleic acids, proteins and low molecular charged compounds
US6074827A (en) 1996-07-30 2000-06-13 Aclara Biosciences, Inc. Microfluidic method for nucleic acid purification and processing
AU746549B2 (en) 1996-11-20 2002-05-02 Becton Dickinson & Company Microfabricated isothermal nucleic acid amplification devices and methods
WO1998040735A1 (en) 1997-03-12 1998-09-17 Kyoto Daiichi Kagaku Co., Ltd. Testing instrument for analyzing liquid sample
AU734957B2 (en) 1997-05-16 2001-06-28 Alberta Research Council Inc. Microfluidic system and methods of use
US6375871B1 (en) 1998-06-18 2002-04-23 3M Innovative Properties Company Methods of manufacturing microfluidic articles
US5992820A (en) 1997-11-19 1999-11-30 Sarnoff Corporation Flow control in microfluidics devices by controlled bubble formation
GB9808836D0 (en) 1998-04-27 1998-06-24 Amersham Pharm Biotech Uk Ltd Microfabricated apparatus for cell based assays
US20040202579A1 (en) 1998-05-08 2004-10-14 Anders Larsson Microfluidic device
EP1121234B1 (en) 1998-10-14 2003-10-01 Gyros AB A matrix and method of producing said matrix
SE9803734D0 (en) * 1998-10-30 1998-10-30 Amersham Pharm Biotech Ab Liquid handling system
US7261859B2 (en) 1998-12-30 2007-08-28 Gyros Ab Microanalysis device
SE9902474D0 (en) 1999-06-30 1999-06-30 Amersham Pharm Biotech Ab Polymer valves
SE9903011D0 (en) 1999-08-26 1999-08-26 Aamic Ab Methods of manufacturing a plastic product and a plastic product forming arrangement utilized for this purpose
SE9903255L (en) 1999-09-13 2001-03-14 Aamic Ab Process for producing a matrix and a matrix thus prepared. (Hybrid application)
GB2355717A (en) 1999-10-28 2001-05-02 Amersham Pharm Biotech Uk Ltd DNA isolation method
SE9904802D0 (en) 1999-12-23 1999-12-23 Amersham Pharm Biotech Ab Microfluidic surfaces
US6884395B2 (en) 2000-05-12 2005-04-26 Gyros Ab Integrated microfluidic disc
SE0000300D0 (en) 2000-01-30 2000-01-30 Amersham Pharm Biotech Ab Microfluidic assembly, covering method for the manufacture of the assembly and the use of the assembly
JP2001293643A (en) * 2000-04-17 2001-10-23 Hirata Corp Production system
SE0001790D0 (en) 2000-05-12 2000-05-12 Aamic Ab Hydrophobic barrier
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
SE0004297D0 (en) 2000-11-23 2000-11-23 Gyros Ab Device for thermal cycling
SE0004594D0 (en) 2000-12-12 2000-12-12 Gyros Ab Microscale nozzie
US6653625B2 (en) 2001-03-19 2003-11-25 Gyros Ab Microfluidic system (MS)
US20040099310A1 (en) 2001-01-05 2004-05-27 Per Andersson Microfluidic device
US7429354B2 (en) 2001-03-19 2008-09-30 Gyros Patent Ab Structural units that define fluidic functions
JP4323806B2 (en) 2001-03-19 2009-09-02 ユィロス・パテント・アクチボラグ Characterization of reaction variables
JP4199544B2 (en) 2001-03-19 2008-12-17 ユィロス・パテント・アクチボラグ Microfluidic system (EDI)
SE0100952D0 (en) 2001-03-19 2001-03-19 Gyros Ab A microfluidic system (MS)
US6717136B2 (en) 2001-03-19 2004-04-06 Gyros Ab Microfludic system (EDI)
US20030013120A1 (en) 2001-07-12 2003-01-16 Patz Edward F. System and method for differential protein expression and a diagnostic biomarker discovery system and method using same
US6919058B2 (en) 2001-08-28 2005-07-19 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
SE0104077D0 (en) 2001-10-21 2001-12-05 Gyros Ab A method and instrumentation for micro dispensation of droplets
US20030054563A1 (en) 2001-09-17 2003-03-20 Gyros Ab Detector arrangement for microfluidic devices
ATE477054T1 (en) 2001-09-17 2010-08-15 Gyros Patent Ab FUNCTIONAL UNIT ALLOWING CONTROLLED FLOW IN A MICROFLUID DEVICE
SE0103109D0 (en) 2001-09-17 2001-09-17 Gyros Microlabs Ab Detector arrangement with rotary drive in an instrument for analysis of microscale liquid sample volumes
SE0103108D0 (en) 2001-09-17 2001-09-17 Gyros Microlabs Ab Rotary drive in an instrument for analysis of microscale liquid sample volumes
US6728644B2 (en) 2001-09-17 2004-04-27 Gyros Ab Method editor
US20050214442A1 (en) 2001-11-27 2005-09-29 Anders Larsson Surface and its manufacture and uses
US7221783B2 (en) 2001-12-31 2007-05-22 Gyros Patent Ab Method and arrangement for reducing noise
US7238255B2 (en) 2001-12-31 2007-07-03 Gyros Patent Ab Microfluidic device and its manufacture
US6637469B2 (en) * 2002-03-19 2003-10-28 Air Products And Chemicals, Inc. Product delivery system for stationary or portable bulk containers
AU2003216002A1 (en) 2002-03-31 2003-10-13 Gyros Ab Efficient mmicrofluidic devices
JP4338529B2 (en) 2002-04-08 2009-10-07 ユロス・パテント・アクチボラゲット Homing process
US6955738B2 (en) 2002-04-09 2005-10-18 Gyros Ab Microfluidic devices with new inner surfaces
US20050277195A1 (en) 2002-04-30 2005-12-15 Gyros Ab Integrated microfluidic device (ea)
EP1509760A1 (en) 2002-05-31 2005-03-02 Gyros AB Detector arrangement based on surface plasmon resonance
JP4519124B2 (en) 2003-01-30 2010-08-04 ユィロス・パテント・アクチボラグ Wall inside the microfluidic device
SE0300822D0 (en) 2003-03-23 2003-03-23 Gyros Ab A collection of Micro Scale Devices
JP5171034B2 (en) 2003-03-23 2013-03-27 ユィロス・パテント・アクチボラグ Filled microscale device
JP2007502428A (en) 2003-05-23 2007-02-08 ユィロス・パテント・アクチボラグ Fluid function based on non-wetting surface
US20050042770A1 (en) 2003-05-23 2005-02-24 Gyros Ab Fluidic functions based on non-wettable surfaces
WO2004106926A1 (en) 2003-06-02 2004-12-09 Gyros Patent Ab Microfluidic affinity assays with improved performance
US7776272B2 (en) 2003-10-03 2010-08-17 Gyros Patent Ab Liquid router
US8592219B2 (en) 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2003A (en) * 1841-03-12 Improvement in horizontal windivhlls
US2002A (en) * 1841-03-12 Tor and planter for plowing
US2005A (en) * 1841-03-16 Improvement in the manner of constructing molds for casting butt-hinges
US2006A (en) * 1841-03-16 Clamp for crimping leather
US4018652A (en) * 1976-01-09 1977-04-19 Mcdonnell Douglas Corporation Process and apparatus for ascertaining the concentration of microorganism in a water specimen
US4077845A (en) * 1977-04-20 1978-03-07 Miles Laboratories, Inc. Disposable inoculation device and process of using same
US4318994A (en) * 1979-08-30 1982-03-09 Mcdonnell Douglas Corporation Enterobacteriaceae species biochemical test card
US4440638A (en) * 1982-02-16 1984-04-03 U.T. Board Of Regents Surface field-effect device for manipulation of charged species
US4661451A (en) * 1984-02-06 1987-04-28 Ortho Diagnostic Systems, Inc. Methods for immobilizing and translocating biological cells
US4868129A (en) * 1987-08-27 1989-09-19 Biotrack Inc. Apparatus and method for dilution and mixing of liquid samples
US4946795A (en) * 1987-08-27 1990-08-07 Biotrack, Inc. Apparatus and method for dilution and mixing of liquid samples
US5190879A (en) * 1990-05-08 1993-03-02 Bowolfe, Inc. Controlled environment animal isolation systems
US5230866A (en) * 1991-03-01 1993-07-27 Biotrack, Inc. Capillary stop-flow junction having improved stability against accidental fluid flow
US5653939A (en) * 1991-11-19 1997-08-05 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection
US5637469A (en) * 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems
US5660993A (en) * 1993-02-18 1997-08-26 Biocircuits Corporation Disposable device in diagnostic assays
US5593838A (en) * 1994-11-10 1997-01-14 David Sarnoff Research Center, Inc. Partitioned microelectronic device array
US5800778A (en) * 1995-05-31 1998-09-01 Biomerieux Vitek, Inc. Sealant for sample holder
US5650334A (en) * 1995-08-31 1997-07-22 First Medical, Inc. Fluorescent labelling compositions and methods for their use
US6299839B1 (en) * 1995-08-31 2001-10-09 First Medical, Inc. System and methods for performing rotor assays
US6319469B1 (en) * 1995-12-18 2001-11-20 Silicon Valley Bank Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
US6143248A (en) * 1996-08-12 2000-11-07 Gamera Bioscience Corp. Capillary microvalve
US6143247A (en) * 1996-12-20 2000-11-07 Gamera Bioscience Inc. Affinity binding-based system for detecting particulates in a fluid
US6296020B1 (en) * 1998-10-13 2001-10-02 Biomicro Systems, Inc. Fluid circuit components based upon passive fluid dynamics
US6591852B1 (en) * 1998-10-13 2003-07-15 Biomicro Systems, Inc. Fluid circuit components based upon passive fluid dynamics
US6967101B1 (en) * 1999-03-24 2005-11-22 Gyros Ab Surface and its manufacture and uses
US6985672B2 (en) * 2000-11-23 2006-01-10 Gyros Ab Device and method for the controlled heating in micro channel systems
US6499499B2 (en) * 2001-04-20 2002-12-31 Nanostream, Inc. Flow control in multi-stream microfluidic devices

Cited By (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090239292A1 (en) * 1998-04-27 2009-09-24 Nicholas Thomas Microfabricated apparatus for cell based assays
US20060194273A1 (en) * 1998-04-27 2006-08-31 Gyros Patent Ab Microfabricated apparatus for cell based assays
US7935522B2 (en) 1998-04-27 2011-05-03 Gyros Patent Ab Microfabricated apparatus for cell based assays
US8030062B2 (en) 1998-04-27 2011-10-04 Gyros Patent Ab Microfabricated apparatus for cell based assays
US8722421B2 (en) 1998-05-08 2014-05-13 Gyros Patent Ab Microfluidic device
US20030143114A1 (en) * 1998-12-30 2003-07-31 Per Andersson Microanalysis device
US7261859B2 (en) 1998-12-30 2007-08-28 Gyros Ab Microanalysis device
US6967101B1 (en) 1999-03-24 2005-11-22 Gyros Ab Surface and its manufacture and uses
US7104517B1 (en) 1999-06-30 2006-09-12 Gyros Patent Ab Polymer valves
US20020125135A1 (en) * 1999-12-23 2002-09-12 Helene Derand Microfluidic surfaces
US7955575B2 (en) 1999-12-23 2011-06-07 Gyros Patent Ab Microfluidic surfaces
US7553393B2 (en) 2000-01-30 2009-06-30 Gyros Ab Method for covering a microfluidic assembly
US20040121454A1 (en) * 2000-03-10 2004-06-24 Bioprocessors Corp. Microreactor
US20030173650A1 (en) * 2000-05-12 2003-09-18 Olle Larsson Micro channel in a substrate
US20070059216A1 (en) * 2000-05-12 2007-03-15 Gyros Patent Ab Hydrophobic Barriers
US20040067051A1 (en) * 2000-11-23 2004-04-08 Gunnar Kylberg Device and method for the controlled heating in micro channel systems
US7668443B2 (en) 2000-11-23 2010-02-23 Gyros Ab Device and method for the controlled heating in micro channel systems
US20060083496A1 (en) * 2000-11-23 2006-04-20 Gunnar Kylberg Device and method for the controlled heating in micro channel systems
US6985672B2 (en) 2000-11-23 2006-01-10 Gyros Ab Device and method for the controlled heating in micro channel systems
US7429354B2 (en) 2001-03-19 2008-09-30 Gyros Patent Ab Structural units that define fluidic functions
US10620194B2 (en) 2001-03-19 2020-04-14 Gyros Patent Ab Characterization of reaction variables
US7148476B2 (en) 2001-03-19 2006-12-12 Gyros Patent Ab Microfluidic system
US20050279925A1 (en) * 2001-03-19 2005-12-22 Per Andersson Microfluidic system
US20070099292A1 (en) * 2001-04-10 2007-05-03 Bioprocessors Corp. Reactor systems having a light-interacting component
US20040132166A1 (en) * 2001-04-10 2004-07-08 Bioprocessors Corp. Determination and/or control of reactor environmental conditions
US20040058437A1 (en) * 2001-04-10 2004-03-25 Rodgers Seth T. Materials and reactor systems having humidity and gas control
US20050032204A1 (en) * 2001-04-10 2005-02-10 Bioprocessors Corp. Microreactor architecture and methods
US20040058407A1 (en) * 2001-04-10 2004-03-25 Miller Scott E. Reactor systems having a light-interacting component
US20030077817A1 (en) * 2001-04-10 2003-04-24 Zarur Andrey J. Microfermentor device and cell based screening method
US7459129B2 (en) 2001-08-28 2008-12-02 Gyros Patent Ab Retaining microfluidic microcavity and other microfluidic structures
US8268262B2 (en) 2001-08-28 2012-09-18 Gyros Patent Ab Retaining microfluidic microcavity and other microfluidic structures
US7300199B2 (en) 2001-08-28 2007-11-27 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20050153434A1 (en) * 2001-08-28 2005-07-14 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20050153432A1 (en) * 2001-08-28 2005-07-14 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20050153433A1 (en) * 2001-08-28 2005-07-14 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20050214442A1 (en) * 2001-11-27 2005-09-29 Anders Larsson Surface and its manufacture and uses
US7238255B2 (en) 2001-12-31 2007-07-03 Gyros Patent Ab Microfluidic device and its manufacture
US7221783B2 (en) 2001-12-31 2007-05-22 Gyros Patent Ab Method and arrangement for reducing noise
US20030129360A1 (en) * 2001-12-31 2003-07-10 Helene Derand Microfluidic device and its manufacture
US20030156763A1 (en) * 2001-12-31 2003-08-21 Gyros Ab. Method and arrangement for reducing noise
US20030211012A1 (en) * 2002-03-31 2003-11-13 Marten Bergstrom Efficient microfluidic devices
US20070009393A1 (en) * 2002-03-31 2007-01-11 Marten Bergstrom Efficient microfluidic devices
US6955738B2 (en) 2002-04-09 2005-10-18 Gyros Ab Microfluidic devices with new inner surfaces
US20050026134A1 (en) * 2002-04-10 2005-02-03 Bioprocessors Corp. Systems and methods for control of pH and other reactor environment conditions
US20050277195A1 (en) * 2002-04-30 2005-12-15 Gyros Ab Integrated microfluidic device (ea)
US20050179901A1 (en) * 2002-05-31 2005-08-18 Gyros Ab Detector arrangement based on surfaces plasmon resonance
US7295320B2 (en) 2002-05-31 2007-11-13 Gyros Ab Detector arrangement based on surfaces plasmon resonance
US20050106714A1 (en) * 2002-06-05 2005-05-19 Zarur Andrey J. Rotatable reactor systems and methods
US7431889B2 (en) 2003-01-30 2008-10-07 Gyros Patent Ab Inner walls of microfluidic devices
US20060110294A1 (en) * 2003-01-30 2006-05-25 Gyros Patent Ab Inner walls of microfluidic devices
US10052630B2 (en) 2003-03-23 2018-08-21 Gyros Patent Ab Preloaded microfluidic devices
US20070054270A1 (en) * 2003-03-23 2007-03-08 Gyros Patent Ab Preloaded microfluidic devices
US20100151594A1 (en) * 2003-03-23 2010-06-17 Inganaes Mats Collection of micro scale devices
US7833486B2 (en) 2003-05-23 2010-11-16 Gyros Patent Ab Hydrophilic/hydrophobic surfaces
US20060246526A1 (en) * 2003-06-02 2006-11-02 Gyros Patent Ab Microfluidic affinity assays with improved performance
US20050026273A1 (en) * 2003-06-05 2005-02-03 Zarur Andrey J. Reactor with memory component
US20090137018A1 (en) * 2003-06-30 2009-05-28 University Of South Florida Magnetic three-dimensional cell culture apparatus and method
US9752139B2 (en) 2003-06-30 2017-09-05 University Of South Florida Magnetic three-dimensional cell culture apparatus and method
US20050054101A1 (en) * 2003-07-17 2005-03-10 Global Cell Solutions Llc Automated cell culture system and process
US9476025B2 (en) 2003-07-23 2016-10-25 University Of South Florida Ferromagnetic cell and tissue culture microcarriers
US7776272B2 (en) 2003-10-03 2010-08-17 Gyros Patent Ab Liquid router
US20050141344A1 (en) * 2003-10-03 2005-06-30 Gyros Ab Liquid router
US20070259109A1 (en) * 2004-01-02 2007-11-08 Gyros Patent Ab Large Scale Surface Modification of Microfluidic Devices
US20090050620A1 (en) * 2004-01-06 2009-02-26 Gyros Ab Contact heating arrangement
US20050186685A1 (en) * 2004-01-17 2005-08-25 Gyros Ab Protecting agent
US20090010819A1 (en) * 2004-01-17 2009-01-08 Gyros Patent Ab Versatile flow path
US20070241061A1 (en) * 2004-01-29 2007-10-18 Johan Engstrom Flow Paths Comprising One or Two Porous Beds
US8133438B2 (en) 2004-01-29 2012-03-13 Gyros Patent Ab Flow paths comprising one or two porous beds
US20050277187A1 (en) * 2004-06-07 2005-12-15 Bioprocessors Corp. Creation of shear in a reactor
US20050271560A1 (en) * 2004-06-07 2005-12-08 Bioprocessors Corp. Gas control in a reactor
US20050287673A1 (en) * 2004-06-07 2005-12-29 Bioprocessors Corp. Reactor mixing
US20060019333A1 (en) * 2004-06-07 2006-01-26 Rodgers Seth T Control of reactor environmental conditions
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20080233607A1 (en) * 2004-11-11 2008-09-25 Hanry Yu Cell Culture Device
EP1815244A1 (en) * 2004-11-11 2007-08-08 Agency for Science, Technology and Research Cell culture device
EP1815244A4 (en) * 2004-11-11 2009-07-22 Agency Science Tech & Res Cell culture device
US20080233594A1 (en) * 2005-01-17 2008-09-25 Gyros Patent Ab Method For Detecting An At Least Bivalent Analyte Using Two Affinity Reactants
US8592219B2 (en) 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
US20090305397A1 (en) * 2005-03-16 2009-12-10 John Robert Dodgson Cellular entity maturation and transportation systems
US7512959B2 (en) 2005-05-09 2009-03-31 Searete Llc Rotation responsive disk activation and deactivation mechanisms
US20070002708A1 (en) * 2005-05-09 2007-01-04 Searete, Llc, A Limited Liability Corporation Of The State Of Delaware Rotation responsive disk activation and deactivation mechanisms
US20060250923A1 (en) * 2005-05-09 2006-11-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for fluid mediated disk activation and deactivation
US20060253692A1 (en) * 2005-05-09 2006-11-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use memory device with associated information
US20060268661A1 (en) * 2005-05-09 2006-11-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluid mediated disk activation and deactivation mechanisms
US8099608B2 (en) 2005-05-09 2012-01-17 The Invention Science Fund I, Llc Limited use data storing device
US20080159108A1 (en) * 2005-05-09 2008-07-03 Searete Llc Method and system for fluid mediated disk activation and deactivation
US8121016B2 (en) 2005-05-09 2012-02-21 The Invention Science Fund I, Llc Rotation responsive disk activation and deactivation mechanisms
US7369471B2 (en) * 2005-05-09 2008-05-06 Searete Llc Method and system for fluid mediated disk activation and deactivation
US7668069B2 (en) 2005-05-09 2010-02-23 Searete Llc Limited use memory device with associated information
US7694316B2 (en) 2005-05-09 2010-04-06 The Invention Science Fund I, Llc Fluid mediated disk activation and deactivation mechanisms
US20070253316A1 (en) * 2005-05-09 2007-11-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method of manufacturing a limited use data storing device
US7748012B2 (en) 2005-05-09 2010-06-29 Searete Llc Method of manufacturing a limited use data storing device
US8745347B2 (en) 2005-05-09 2014-06-03 The Invention Science Fund I, Llc Limited use data storing device
US8220014B2 (en) 2005-05-09 2012-07-10 The Invention Science Fund I, Llc Modifiable memory devices having limited expected lifetime
US20060291354A1 (en) * 2005-05-09 2006-12-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for fluid mediated disk activation and deactivation
US7778124B2 (en) 2005-05-09 2010-08-17 Invention Science Fund 1, Llc Method and system for fluid mediated disk activation and deactivation
US7796485B2 (en) 2005-05-09 2010-09-14 Invention Science Fund 1, Llc Method and system for fluid mediated disk activation and deactivation
US20070070868A1 (en) * 2005-05-09 2007-03-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluid mediated disk activation and deactivation mechanisms
US8089839B2 (en) 2005-05-09 2012-01-03 The Invention Science Fund I, Llc Method and system for fluid mediated disk activation and deactivation
US8462605B2 (en) 2005-05-09 2013-06-11 The Invention Science Fund I, Llc Method of manufacturing a limited use data storing device
US8218262B2 (en) 2005-05-09 2012-07-10 The Invention Science Fund I, Llc Method of manufacturing a limited use data storing device including structured data and primary and secondary read-support information
US7916592B2 (en) 2005-05-09 2011-03-29 The Invention Science Fund I, Llc Fluid mediated disk activation and deactivation mechanisms
US20070033352A1 (en) * 2005-05-09 2007-02-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use data storing device
US7916615B2 (en) 2005-06-09 2011-03-29 The Invention Science Fund I, Llc Method and system for rotational control of data storage devices
US20060280088A1 (en) * 2005-06-09 2006-12-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Rotation responsive disk activation and deactivation mechanisms
US7668068B2 (en) 2005-06-09 2010-02-23 Searete Llc Rotation responsive disk activation and deactivation mechanisms
US20060279874A1 (en) * 2005-06-09 2006-12-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for rotational control of data storage devices
US9396752B2 (en) 2005-08-05 2016-07-19 Searete Llc Memory device activation and deactivation
US20070041231A1 (en) * 2005-08-05 2007-02-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Memory device activation and deactivation
US20090122666A1 (en) * 2005-08-05 2009-05-14 Searete Llc Limited use memory device with associated information
US8159925B2 (en) 2005-08-05 2012-04-17 The Invention Science Fund I, Llc Limited use memory device with associated information
US20090035793A1 (en) * 2005-08-31 2009-02-05 Nissan Chemical Industries, Ltd. Microchip for cell response evaluation
US7770028B2 (en) 2005-09-09 2010-08-03 Invention Science Fund 1, Llc Limited use data storing device
US20090122670A1 (en) * 2005-09-09 2009-05-14 Searete Llc Data retrieval systems
US20070058450A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Limited use data storing device
US20070058505A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Data retrieval systems
US20090122660A1 (en) * 2005-09-09 2009-05-14 Searete Llc. Data retrieval systems
US8140745B2 (en) 2005-09-09 2012-03-20 The Invention Science Fund I, Llc Data retrieval methods
US20070061370A1 (en) * 2005-09-09 2007-03-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Data retrieval methods
US8032798B2 (en) 2005-09-09 2011-10-04 The Invention Science Fund I, Llc Data retrieval systems
US8332724B2 (en) 2005-09-09 2012-12-11 The Invention Science Fund I, Llc Data retrieval systems
US20110116972A1 (en) * 2005-12-12 2011-05-19 Mats Holmquist Microfluidic assays and microfluidic devices
US20070134739A1 (en) * 2005-12-12 2007-06-14 Gyros Patent Ab Microfluidic assays and microfluidic devices
US8432777B2 (en) 2006-06-19 2013-04-30 The Invention Science Fund I, Llc Method and system for fluid mediated disk activation and deactivation
US8264928B2 (en) 2006-06-19 2012-09-11 The Invention Science Fund I, Llc Method and system for fluid mediated disk activation and deactivation
US20110002207A1 (en) * 2006-06-19 2011-01-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method and system for fluid mediated disk activation and deactivation
US7907486B2 (en) 2006-06-20 2011-03-15 The Invention Science Fund I, Llc Rotation responsive disk activation and deactivation mechanisms
US20090022023A1 (en) * 2006-06-20 2009-01-22 Searete Llc Rotation responsive disk activation and deactivation mechanisms
US20110189056A1 (en) * 2007-10-11 2011-08-04 Accelbeam Devices, Llc Microwave reactor
US8389277B2 (en) 2007-10-11 2013-03-05 Agency For Science, Technology And Research Forming cell structure with transient linker in cage
US20110236924A1 (en) * 2008-12-19 2011-09-29 Halverson Kurt J System and method for processing samples
US9388448B2 (en) 2008-12-19 2016-07-12 3M Innovative Properties Company System and method for processing samples
US8647508B2 (en) 2008-12-19 2014-02-11 3M Innovative Properties Company System and method for processing samples
US8535945B2 (en) 2008-12-19 2013-09-17 3M Innovative Properties Company System and method for concentrating samples
US20100167355A1 (en) * 2008-12-29 2010-07-01 Stmicroelectronics S.R.L. Microreactor with vent channels for removing air from a reaction chamber
US9561504B2 (en) * 2008-12-29 2017-02-07 Stmicroelectronics S.R.L. Microreactor with vent channels for removing air from a reaction chamber
US9616423B2 (en) 2008-12-29 2017-04-11 Stmicroelectronics S.R.L. Microreactor with vent channels for removing air from a reaction chamber
US20120264654A1 (en) * 2009-12-28 2012-10-18 Dhananjaya Dendukuri Diagnostic element, and a diagnostic device comprising a diagnostic element
US9470612B2 (en) 2011-06-30 2016-10-18 3M Innovative Properties Company Systems and methods for detecting an analyte of interest in a sample using filters and microstructured surfaces
US9909969B2 (en) 2011-06-30 2018-03-06 3M Innovative Properties Company Systems and methods for detecting an analyte of interest in a sample using microstructured surfaces
US9488563B2 (en) 2011-06-30 2016-11-08 3M Innovative Properties Company Systems and methods for detecting an analyte of interest in a sample using microstructured surfaces
CN103323605A (en) * 2013-06-18 2013-09-25 杭州普施康生物科技有限公司 Micro-fluidic chip for glycosylated hemoglobin immunodetection
US20170336399A1 (en) * 2014-11-14 2017-11-23 Yale University Novel methods and devices for high-throughput quantification, detection and temporal profiling of cellular secretions, and compositions identified using same
CN104502617A (en) * 2014-12-24 2015-04-08 杭州霆科生物科技有限公司 Full-automatic and high-throughput micro-fluidic chip system and method for detecting pesticide residue
US10689608B2 (en) 2015-08-26 2020-06-23 EMULATE, Inc. Droplet fluid connections
US10519410B2 (en) 2015-08-26 2019-12-31 Emulate, Inc Pressure manifold and culture module
US10913924B2 (en) 2015-08-26 2021-02-09 EMULATE, Inc. Controlling pressure
US10988722B2 (en) 2015-08-26 2021-04-27 EMULATE, Inc. Perfusion manifold assembly
US10988721B2 (en) 2015-08-26 2021-04-27 EMULATE, Inc. Controlling pressure
US11820966B2 (en) 2015-08-26 2023-11-21 EMULATE, Inc. Pressure manifold and culture module
US11834641B2 (en) 2015-08-26 2023-12-05 EMULATE, Inc. Controlling pressure
US11920114B2 (en) 2015-08-26 2024-03-05 EMULATE, Inc. Controlling pressure
US10408821B2 (en) * 2016-04-14 2019-09-10 Triad National Security, Llc Microfluidic aspirator and methods of making and using the same
US11287358B1 (en) 2016-04-14 2022-03-29 Triad National Security, Llc Microfluidic aspirator and multi-purpose flow sensor and methods of making and using the same
CN113155588A (en) * 2021-05-13 2021-07-23 武汉新烽光电股份有限公司 Rapid automatic water quality detection system and method based on micro-fluidic

Also Published As

Publication number Publication date
DE69909462D1 (en) 2003-08-14
US8030062B2 (en) 2011-10-04
US20120003682A1 (en) 2012-01-05
ATE342347T1 (en) 2006-11-15
CA2330034A1 (en) 1999-11-04
EP1298198A3 (en) 2004-02-11
US6632656B1 (en) 2003-10-14
WO1999055827A1 (en) 1999-11-04
US20090239292A1 (en) 2009-09-24
US7935522B2 (en) 2011-05-03
US20060194273A1 (en) 2006-08-31
EP1073709B1 (en) 2003-07-09
DE69933588T2 (en) 2007-08-16
DE69933588D1 (en) 2006-11-23
JP2002512783A (en) 2002-05-08
DE69909462T2 (en) 2004-04-15
ES2203098T3 (en) 2004-04-01
GB9808836D0 (en) 1998-06-24
EP1298198A2 (en) 2003-04-02
ATE244755T1 (en) 2003-07-15
EP1298198B1 (en) 2006-10-11
JP4064631B2 (en) 2008-03-19
EP1073709A1 (en) 2001-02-07
DK1073709T3 (en) 2003-11-03

Similar Documents

Publication Publication Date Title
US6632656B1 (en) Microfabricated apparatus for cell based assays
US10190082B2 (en) Multiwell plate
JP2002512783A5 (en)
US8481325B2 (en) Device for studying individual cells
AU2003204160B2 (en) Self-aliquoting sample storage plate system
Pasirayi et al. Microfluidic bioreactors for cell culturing: a review
JP2003533681A (en) Microfluidic device and method for performing cell-based analysis
CN110087772B (en) Chip platform for microarray 3D (three-dimensional) biological printing
US20030044853A1 (en) Method for conducting cell-based analyses using laminar flow, and device therefor
US20030157586A1 (en) Device and method for conducting cellular assays using multiple fluid flow
US20030044879A1 (en) Method and device for forming a concentration gradient for chemotactic evaluation through use of laminar flow
US20030044766A1 (en) Methods and devices for detecting cell-cell interactions
US20030044992A1 (en) Cell-based multiplexing ADME analysis using focused fluid flow
US20220297126A1 (en) Microfluidic Pipette Aspirators for Large-Scale Analysis of Single Cells, Clusters and Their Sub-Populations
Nahmias Microdevices in biology and medicine
JP2023518311A (en) Methods and apparatus for cell-based assays
Nelson A Multi-Well Concentration Gradient Drug Delivery Microfluidic Device For High-Content And High-Throughput Screening
Folch et al. Cell Biology on a Chip: A Microfluidic Cell Culture Laboratory
IL184818A (en) Device for studying individual cells

Legal Events

Date Code Title Description
AS Assignment

Owner name: GYROS AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ANDERSSON, PER;REEL/FRAME:014756/0720

Effective date: 20030903

AS Assignment

Owner name: NORADA HOLDING AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:GYROS AB;REEL/FRAME:016883/0789

Effective date: 20050711

Owner name: GYROS PATENT AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORADA HOLDING AB;REEL/FRAME:016883/0796

Effective date: 20051212

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: GYROS AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMERSHAM PHARMACIA BIOTECH AB;REEL/FRAME:025676/0631

Effective date: 20010707

Owner name: AMERSHAM PHARMACIA BIOTECH UK LTD., UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THOMAS, NICHOLAS;REEL/FRAME:025676/0558

Effective date: 20000530